#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Individual Variation in Brain Network Topology Is Linked to Emotional Intelligence Background Social cognitive ability is a significant determinant of functional outcome, and deficits in social cognition are a disabling symptom of psychotic disorders.
1-1	0-10	Individual	_
1-2	11-20	Variation	_
1-3	21-23	in	_
1-4	24-29	Brain	_
1-5	30-37	Network	_
1-6	38-46	Topology	_
1-7	47-49	Is	_
1-8	50-56	Linked	_
1-9	57-59	to	_
1-10	60-69	Emotional	_
1-11	70-82	Intelligence	_
1-12	83-93	Background	_
1-13	94-100	Social	_
1-14	101-110	cognitive	_
1-15	111-118	ability	_
1-16	119-121	is	_
1-17	122-123	a	_
1-18	124-135	significant	_
1-19	136-147	determinant	_
1-20	148-150	of	_
1-21	151-161	functional	_
1-22	162-169	outcome	_
1-23	170-171	,	_
1-24	172-175	and	_
1-25	176-184	deficits	_
1-26	185-187	in	_
1-27	188-194	social	_
1-28	195-204	cognition	_
1-29	205-208	are	_
1-30	209-210	a	_
1-31	211-220	disabling	_
1-32	221-228	symptom	_
1-33	229-231	of	_
1-34	232-241	psychotic	_
1-35	242-251	disorders	_
1-36	252-253	.	_

Text=The neurobiological underpinnings of social cognition are not well understood, hampering our ability to ameliorate these deficits.
2-1	254-257	The	_
2-2	258-273	neurobiological	_
2-3	274-287	underpinnings	_
2-4	288-290	of	_
2-5	291-297	social	_
2-6	298-307	cognition	_
2-7	308-311	are	_
2-8	312-315	not	_
2-9	316-320	well	_
2-10	321-331	understood	_
2-11	332-333	,	_
2-12	334-343	hampering	_
2-13	344-347	our	_
2-14	348-355	ability	_
2-15	356-358	to	_
2-16	359-369	ameliorate	_
2-17	370-375	these	_
2-18	376-384	deficits	_
2-19	385-386	.	_

Text=Objective Using ‘ resting state ’ functional magnetic resonance imaging (rsfMRI) and a trans-diagnostic, data-driven analytic strategy, we sought to identify the brain network basis of emotional intelligence, a key domain of social cognition.
3-1	387-396	Objective	_
3-2	397-402	Using	_
3-3	403-404	‘	_
3-4	405-412	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
3-5	413-418	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
3-6	419-420	’	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
3-7	421-431	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-8	432-440	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-9	441-450	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-10	451-458	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-11	459-460	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-12	461-467	rsfMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-13	468-469	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-14	470-473	and	_
3-15	474-475	a	_
3-16	476-492	trans-diagnostic	_
3-17	493-494	,	_
3-18	495-506	data-driven	_
3-19	507-515	analytic	_
3-20	516-524	strategy	_
3-21	525-526	,	_
3-22	527-529	we	_
3-23	530-536	sought	_
3-24	537-539	to	_
3-25	540-548	identify	_
3-26	549-552	the	_
3-27	553-558	brain	_
3-28	559-566	network	_
3-29	567-572	basis	_
3-30	573-575	of	_
3-31	576-585	emotional	_
3-32	586-598	intelligence	_
3-33	599-600	,	_
3-34	601-602	a	_
3-35	603-606	key	_
3-36	607-613	domain	_
3-37	614-616	of	_
3-38	617-623	social	_
3-39	624-633	cognition	_
3-40	634-635	.	_

Text=Methods The study included 60 participants with a diagnosis of schizophrenia or schizoaffective disorder and 45 healthy controls.
4-1	636-643	Methods	_
4-2	644-647	The	_
4-3	648-653	study	_
4-4	654-662	included	_
4-5	663-665	60	_
4-6	666-678	participants	_
4-7	679-683	with	_
4-8	684-685	a	_
4-9	686-695	diagnosis	_
4-10	696-698	of	_
4-11	699-712	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-12	713-715	or	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-13	716-731	schizoaffective	http://maven.renci.org/NeuroBridge/neurobridge#BipolarTypeSchizoaffectiveDisorder
4-14	732-740	disorder	http://maven.renci.org/NeuroBridge/neurobridge#BipolarTypeSchizoaffectiveDisorder
4-15	741-744	and	_
4-16	745-747	45	_
4-17	748-755	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-18	756-764	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-19	765-766	.	_

Text=All participants underwent a rsfMRI scan.
5-1	767-770	All	_
5-2	771-783	participants	_
5-3	784-793	underwent	_
5-4	794-795	a	_
5-5	796-802	rsfMRI	http://maven.renci.org/NeuroBridge/neurobridge#ComputedTomographyScan
5-6	803-807	scan	http://maven.renci.org/NeuroBridge/neurobridge#ComputedTomographyScan
5-7	808-809	.	_

Text=Emotional Intelligence was measured using the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT).
6-1	810-819	Emotional	_
6-2	820-832	Intelligence	_
6-3	833-836	was	_
6-4	837-845	measured	_
6-5	846-851	using	_
6-6	852-855	the	_
6-7	856-876	Mayer-Salovey-Caruso	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
6-8	877-886	Emotional	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
6-9	887-899	Intelligence	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
6-10	900-904	Test	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
6-11	905-906	(	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
6-12	907-913	MSCEIT	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
6-13	914-915	)	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
6-14	916-917	.	_

Text=A connectome-wide analysis examined how each individual brain voxel ’ s connectivity correlated with emotional intelligence using multivariate distance matrix regression (MDMR).
7-1	918-919	A	_
7-2	920-935	connectome-wide	_
7-3	936-944	analysis	_
7-4	945-953	examined	_
7-5	954-957	how	_
7-6	958-962	each	_
7-7	963-973	individual	_
7-8	974-979	brain	_
7-9	980-985	voxel	_
7-10	986-987	’	_
7-11	988-989	s	_
7-12	990-1002	connectivity	_
7-13	1003-1013	correlated	_
7-14	1014-1018	with	_
7-15	1019-1028	emotional	_
7-16	1029-1041	intelligence	_
7-17	1042-1047	using	_
7-18	1048-1060	multivariate	_
7-19	1061-1069	distance	_
7-20	1070-1076	matrix	_
7-21	1077-1087	regression	_
7-22	1088-1089	(	_
7-23	1090-1094	MDMR	_
7-24	1095-1096	)	_
7-25	1097-1098	.	_

Text=Results We identified a region in the left superior parietal lobule (SPL) where individual network topology is linked to emotional intelligence.
8-1	1099-1106	Results	_
8-2	1107-1109	We	_
8-3	1110-1120	identified	_
8-4	1121-1122	a	_
8-5	1123-1129	region	_
8-6	1130-1132	in	_
8-7	1133-1136	the	_
8-8	1137-1141	left	_
8-9	1142-1150	superior	_
8-10	1151-1159	parietal	_
8-11	1160-1166	lobule	_
8-12	1167-1168	(	_
8-13	1169-1172	SPL	_
8-14	1173-1174	)	_
8-15	1175-1180	where	_
8-16	1181-1191	individual	_
8-17	1192-1199	network	_
8-18	1200-1208	topology	_
8-19	1209-1211	is	_
8-20	1212-1218	linked	_
8-21	1219-1221	to	_
8-22	1222-1231	emotional	_
8-23	1232-1244	intelligence	_
8-24	1245-1246	.	_

Text=Specifically, in high scoring individuals, this region is a node of the Default Mode Network and in low scoring individuals, it is a node of the Dorsal Attention Network.
9-1	1247-1259	Specifically	_
9-2	1260-1261	,	_
9-3	1262-1264	in	_
9-4	1265-1269	high	_
9-5	1270-1277	scoring	_
9-6	1278-1289	individuals	_
9-7	1290-1291	,	_
9-8	1292-1296	this	_
9-9	1297-1303	region	_
9-10	1304-1306	is	_
9-11	1307-1308	a	_
9-12	1309-1313	node	_
9-13	1314-1316	of	_
9-14	1317-1320	the	_
9-15	1321-1328	Default	_
9-16	1329-1333	Mode	_
9-17	1334-1341	Network	_
9-18	1342-1345	and	_
9-19	1346-1348	in	_
9-20	1349-1352	low	_
9-21	1353-1360	scoring	_
9-22	1361-1372	individuals	_
9-23	1373-1374	,	_
9-24	1375-1377	it	_
9-25	1378-1380	is	_
9-26	1381-1382	a	_
9-27	1383-1387	node	_
9-28	1388-1390	of	_
9-29	1391-1394	the	_
9-30	1395-1401	Dorsal	_
9-31	1402-1411	Attention	_
9-32	1412-1419	Network	_
9-33	1420-1421	.	_

Text=This relationship was observed in both schizophrenia and healthy comparison participants.
10-1	1422-1426	This	_
10-2	1427-1439	relationship	_
10-3	1440-1443	was	_
10-4	1444-1452	observed	_
10-5	1453-1455	in	_
10-6	1456-1460	both	_
10-7	1461-1474	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-8	1475-1478	and	_
10-9	1479-1486	healthy	_
10-10	1487-1497	comparison	_
10-11	1498-1510	participants	_
10-12	1511-1512	.	_

Text=Conclusion Prior studies have demonstrated individual variance in the topology of canonical resting state networks but the cognitive or behavioral relevance of these differences has largely been undetermined.
11-1	1513-1523	Conclusion	_
11-2	1524-1529	Prior	_
11-3	1530-1537	studies	_
11-4	1538-1542	have	_
11-5	1543-1555	demonstrated	_
11-6	1556-1566	individual	_
11-7	1567-1575	variance	_
11-8	1576-1578	in	_
11-9	1579-1582	the	_
11-10	1583-1591	topology	_
11-11	1592-1594	of	_
11-12	1595-1604	canonical	_
11-13	1605-1612	resting	_
11-14	1613-1618	state	_
11-15	1619-1627	networks	_
11-16	1628-1631	but	_
11-17	1632-1635	the	_
11-18	1636-1645	cognitive	_
11-19	1646-1648	or	_
11-20	1649-1659	behavioral	_
11-21	1660-1669	relevance	_
11-22	1670-1672	of	_
11-23	1673-1678	these	_
11-24	1679-1690	differences	_
11-25	1691-1694	has	_
11-26	1695-1702	largely	_
11-27	1703-1707	been	_
11-28	1708-1720	undetermined	_
11-29	1721-1722	.	_

Text=We observe that the left SPL, a region of high individual variance at the cytoarchitectonic level, also demonstrates individual variance in its association with large scale resting-state networks and that network topology is linked to emotional intelligence.
12-1	1723-1725	We	_
12-2	1726-1733	observe	_
12-3	1734-1738	that	_
12-4	1739-1742	the	_
12-5	1743-1747	left	_
12-6	1748-1751	SPL	_
12-7	1752-1753	,	_
12-8	1754-1755	a	_
12-9	1756-1762	region	_
12-10	1763-1765	of	_
12-11	1766-1770	high	_
12-12	1771-1781	individual	_
12-13	1782-1790	variance	_
12-14	1791-1793	at	_
12-15	1794-1797	the	_
12-16	1798-1815	cytoarchitectonic	_
12-17	1816-1821	level	_
12-18	1822-1823	,	_
12-19	1824-1828	also	_
12-20	1829-1841	demonstrates	_
12-21	1842-1852	individual	_
12-22	1853-1861	variance	_
12-23	1862-1864	in	_
12-24	1865-1868	its	_
12-25	1869-1880	association	_
12-26	1881-1885	with	_
12-27	1886-1891	large	_
12-28	1892-1897	scale	_
12-29	1898-1911	resting-state	_
12-30	1912-1920	networks	_
12-31	1921-1924	and	_
12-32	1925-1929	that	_
12-33	1930-1937	network	_
12-34	1938-1946	topology	_
12-35	1947-1949	is	_
12-36	1950-1956	linked	_
12-37	1957-1959	to	_
12-38	1960-1969	emotional	_
12-39	1970-1982	intelligence	_
12-40	1983-1984	.	_

Text=Material and Methods Participants The study was approved by the Institutional Review Boards of the University of Pittsburgh (Pittsburgh, PA), McLean Hospital (Belmont, MA), and Beth-Israel Deaconess Medical Center (Boston, MA), and all participants gave written informed consent before participating.
13-1	1985-1993	Material	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
13-2	1994-1997	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
13-3	1998-2005	Methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
13-4	2006-2018	Participants	_
13-5	2019-2022	The	_
13-6	2023-2028	study	_
13-7	2029-2032	was	_
13-8	2033-2041	approved	_
13-9	2042-2044	by	_
13-10	2045-2048	the	_
13-11	2049-2062	Institutional	_
13-12	2063-2069	Review	_
13-13	2070-2076	Boards	_
13-14	2077-2079	of	_
13-15	2080-2083	the	_
13-16	2084-2094	University	_
13-17	2095-2097	of	_
13-18	2098-2108	Pittsburgh	_
13-19	2109-2110	(	_
13-20	2111-2121	Pittsburgh	_
13-21	2122-2123	,	_
13-22	2124-2126	PA	_
13-23	2127-2128	)	_
13-24	2129-2130	,	_
13-25	2131-2137	McLean	_
13-26	2138-2146	Hospital	_
13-27	2147-2148	(	_
13-28	2149-2156	Belmont	_
13-29	2157-2158	,	_
13-30	2159-2161	MA	_
13-31	2162-2163	)	_
13-32	2164-2165	,	_
13-33	2166-2169	and	_
13-34	2170-2181	Beth-Israel	_
13-35	2182-2191	Deaconess	_
13-36	2192-2199	Medical	_
13-37	2200-2206	Center	_
13-38	2207-2208	(	_
13-39	2209-2215	Boston	_
13-40	2216-2217	,	_
13-41	2218-2220	MA	_
13-42	2221-2222	)	_
13-43	2223-2224	,	_
13-44	2225-2228	and	_
13-45	2229-2232	all	_
13-46	2233-2245	participants	_
13-47	2246-2250	gave	_
13-48	2251-2258	written	_
13-49	2259-2267	informed	_
13-50	2268-2275	consent	_
13-51	2276-2282	before	_
13-52	2283-2296	participating	_
13-53	2297-2298	.	_

Text=Participants were recruited from health centers using a variety of means including early psychosis treatment programs and community referral networks.
14-1	2299-2311	Participants	_
14-2	2312-2316	were	_
14-3	2317-2326	recruited	_
14-4	2327-2331	from	_
14-5	2332-2338	health	_
14-6	2339-2346	centers	_
14-7	2347-2352	using	_
14-8	2353-2354	a	_
14-9	2355-2362	variety	_
14-10	2363-2365	of	_
14-11	2366-2371	means	_
14-12	2372-2381	including	_
14-13	2382-2387	early	_
14-14	2388-2397	psychosis	_
14-15	2398-2407	treatment	_
14-16	2408-2416	programs	_
14-17	2417-2420	and	_
14-18	2421-2430	community	_
14-19	2431-2439	referral	_
14-20	2440-2448	networks	_
14-21	2449-2450	.	_

Text=Participants at the Boston and Pittsburgh sites were recruited for a clinical trial (BICEPS,).
15-1	2451-2463	Participants	_
15-2	2464-2466	at	_
15-3	2467-2470	the	_
15-4	2471-2477	Boston	_
15-5	2478-2481	and	_
15-6	2482-2492	Pittsburgh	_
15-7	2493-2498	sites	_
15-8	2499-2503	were	_
15-9	2504-2513	recruited	_
15-10	2514-2517	for	_
15-11	2518-2519	a	_
15-12	2520-2528	clinical	_
15-13	2529-2534	trial	_
15-14	2535-2536	(	_
15-15	2537-2543	BICEPS	_
15-16	2544-2545	,	_
15-17	2546-2547	)	_
15-18	2548-2549	.	_

Text=Clinical and imaging data analyzed here was from participants ’ baseline (pre-intervention) evaluation.
16-1	2550-2558	Clinical	_
16-2	2559-2562	and	_
16-3	2563-2570	imaging	_
16-4	2571-2575	data	_
16-5	2576-2584	analyzed	_
16-6	2585-2589	here	_
16-7	2590-2593	was	_
16-8	2594-2598	from	_
16-9	2599-2611	participants	_
16-10	2612-2613	’	_
16-11	2614-2622	baseline	_
16-12	2623-2624	(	_
16-13	2625-2641	pre-intervention	_
16-14	2642-2643	)	_
16-15	2644-2654	evaluation	_
16-16	2655-2656	.	_

Text=Diagnosis was determined using the Structured Clinical Interview for the DSM-IV (SCID).
17-1	2657-2666	Diagnosis	_
17-2	2667-2670	was	_
17-3	2671-2681	determined	_
17-4	2682-2687	using	_
17-5	2688-2691	the	_
17-6	2692-2702	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-7	2703-2711	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-8	2712-2721	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-9	2722-2725	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-10	2726-2729	the	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-11	2730-2736	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-12	2737-2738	(	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-13	2739-2743	SCID	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-14	2744-2745	)	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-15	2746-2747	.	_

Text=Patients were assessed by raters trained in the administration and scoring of the SCID.
18-1	2748-2756	Patients	_
18-2	2757-2761	were	_
18-3	2762-2770	assessed	_
18-4	2771-2773	by	_
18-5	2774-2780	raters	_
18-6	2781-2788	trained	_
18-7	2789-2791	in	_
18-8	2792-2795	the	_
18-9	2796-2810	administration	_
18-10	2811-2814	and	_
18-11	2815-2822	scoring	_
18-12	2823-2825	of	_
18-13	2826-2829	the	_
18-14	2830-2834	SCID	_
18-15	2835-2836	.	_

Text=Inclusion criteria for all participants included: (1) age 18–45 years; (2) current IQ ≥ 80 as assessed using the WASI-II; and (3) the ability to read (sixth grade level or higher) and speak fluent English.
19-1	2837-2846	Inclusion	_
19-2	2847-2855	criteria	_
19-3	2856-2859	for	_
19-4	2860-2863	all	_
19-5	2864-2876	participants	_
19-6	2877-2885	included	_
19-7	2886-2887	:	_
19-8	2888-2889	(	_
19-9	2890-2891	1	_
19-10	2892-2893	)	_
19-11	2894-2897	age	_
19-12	2898-2903	18–45	_
19-13	2904-2909	years	_
19-14	2910-2911	;	_
19-15	2912-2913	(	_
19-16	2914-2915	2	_
19-17	2916-2917	)	_
19-18	2918-2925	current	_
19-19	2926-2928	IQ	_
19-20	2929-2930	≥	_
19-21	2931-2933	80	_
19-22	2934-2936	as	_
19-23	2937-2945	assessed	_
19-24	2946-2951	using	_
19-25	2952-2955	the	_
19-26	2956-2963	WASI-II	_
19-27	2964-2965	;	_
19-28	2966-2969	and	_
19-29	2970-2971	(	_
19-30	2972-2973	3	_
19-31	2974-2975	)	_
19-32	2976-2979	the	_
19-33	2980-2987	ability	_
19-34	2988-2990	to	_
19-35	2991-2995	read	_
19-36	2996-2997	(	_
19-37	2998-3003	sixth	_
19-38	3004-3009	grade	_
19-39	3010-3015	level	_
19-40	3016-3018	or	_
19-41	3019-3025	higher	_
19-42	3026-3027	)	_
19-43	3028-3031	and	_
19-44	3032-3037	speak	_
19-45	3038-3044	fluent	_
19-46	3045-3052	English	_
19-47	3053-3054	.	_

Text=Additional inclusion criteria for psychotic disorder participants were (1) a diagnosis of schizophrenia or schizoaffective disorder verified using the SCID interview; (2) time since first psychotic symptom of ≤ 8 years; and (3) clinically stabilized on antipsychotic medication (assessed via SCID in consensus conferences).
20-1	3055-3065	Additional	_
20-2	3066-3075	inclusion	_
20-3	3076-3084	criteria	_
20-4	3085-3088	for	_
20-5	3089-3098	psychotic	_
20-6	3099-3107	disorder	_
20-7	3108-3120	participants	_
20-8	3121-3125	were	_
20-9	3126-3127	(	_
20-10	3128-3129	1	_
20-11	3130-3131	)	_
20-12	3132-3133	a	_
20-13	3134-3143	diagnosis	_
20-14	3144-3146	of	_
20-15	3147-3160	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
20-16	3161-3163	or	_
20-17	3164-3179	schizoaffective	http://maven.renci.org/NeuroBridge/neurobridge#BipolarTypeSchizoaffectiveDisorder
20-18	3180-3188	disorder	http://maven.renci.org/NeuroBridge/neurobridge#BipolarTypeSchizoaffectiveDisorder
20-19	3189-3197	verified	_
20-20	3198-3203	using	_
20-21	3204-3207	the	_
20-22	3208-3212	SCID	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
20-23	3213-3222	interview	_
20-24	3223-3224	;	_
20-25	3225-3226	(	_
20-26	3227-3228	2	_
20-27	3229-3230	)	_
20-28	3231-3235	time	_
20-29	3236-3241	since	_
20-30	3242-3247	first	_
20-31	3248-3257	psychotic	_
20-32	3258-3265	symptom	_
20-33	3266-3268	of	_
20-34	3269-3270	≤	_
20-35	3271-3272	8	_
20-36	3273-3278	years	_
20-37	3279-3280	;	_
20-38	3281-3284	and	_
20-39	3285-3286	(	_
20-40	3287-3288	3	_
20-41	3289-3290	)	_
20-42	3291-3301	clinically	_
20-43	3302-3312	stabilized	_
20-44	3313-3315	on	_
20-45	3316-3329	antipsychotic	_
20-46	3330-3340	medication	_
20-47	3341-3342	(	_
20-48	3343-3351	assessed	_
20-49	3352-3355	via	_
20-50	3356-3360	SCID	_
20-51	3361-3363	in	_
20-52	3364-3373	consensus	_
20-53	3374-3385	conferences	_
20-54	3386-3387	)	_
20-55	3388-3389	.	_

Text=Healthy comparison (HC) participants did not meet criteria for any Axis I psychiatric disorder currently or historically.
21-1	3390-3397	Healthy	http://maven.renci.org/NeuroBridge/neurobridge#Comparison
21-2	3398-3408	comparison	http://maven.renci.org/NeuroBridge/neurobridge#Comparison
21-3	3409-3410	(	http://maven.renci.org/NeuroBridge/neurobridge#Comparison
21-4	3411-3413	HC	http://maven.renci.org/NeuroBridge/neurobridge#Thing
21-5	3414-3415	)	http://maven.renci.org/NeuroBridge/neurobridge#Thing
21-6	3416-3428	participants	_
21-7	3429-3432	did	_
21-8	3433-3436	not	_
21-9	3437-3441	meet	_
21-10	3442-3450	criteria	_
21-11	3451-3454	for	_
21-12	3455-3458	any	_
21-13	3459-3463	Axis	_
21-14	3464-3465	I	_
21-15	3466-3477	psychiatric	_
21-16	3478-3486	disorder	_
21-17	3487-3496	currently	_
21-18	3497-3499	or	_
21-19	3500-3512	historically	_
21-20	3513-3514	.	_

Text=Exclusion criteria were (1) significant neurological or medical disorders that may produce cognitive impairment (e.g., seizure disorder, traumatic brain injury); (2) persistent suicidal or homicidal behavior; (3) a recent history of substance abuse or dependence (within the past 3 months); (4) any MRI contraindications and (5) decisional incapacity requiring a guardian.
22-1	3515-3524	Exclusion	_
22-2	3525-3533	criteria	_
22-3	3534-3538	were	_
22-4	3539-3540	(	_
22-5	3541-3542	1	_
22-6	3543-3544	)	_
22-7	3545-3556	significant	_
22-8	3557-3569	neurological	_
22-9	3570-3572	or	_
22-10	3573-3580	medical	_
22-11	3581-3590	disorders	_
22-12	3591-3595	that	_
22-13	3596-3599	may	_
22-14	3600-3607	produce	_
22-15	3608-3617	cognitive	_
22-16	3618-3628	impairment	_
22-17	3629-3630	(	_
22-18	3631-3635	e.g.	_
22-19	3636-3637	,	_
22-20	3638-3645	seizure	_
22-21	3646-3654	disorder	_
22-22	3655-3656	,	_
22-23	3657-3666	traumatic	_
22-24	3667-3672	brain	_
22-25	3673-3679	injury	_
22-26	3680-3681	)	_
22-27	3682-3683	;	_
22-28	3684-3685	(	_
22-29	3686-3687	2	_
22-30	3688-3689	)	_
22-31	3690-3700	persistent	_
22-32	3701-3709	suicidal	_
22-33	3710-3712	or	_
22-34	3713-3722	homicidal	_
22-35	3723-3731	behavior	_
22-36	3732-3733	;	_
22-37	3734-3735	(	_
22-38	3736-3737	3	_
22-39	3738-3739	)	_
22-40	3740-3741	a	_
22-41	3742-3748	recent	_
22-42	3749-3756	history	_
22-43	3757-3759	of	_
22-44	3760-3769	substance	_
22-45	3770-3775	abuse	_
22-46	3776-3778	or	_
22-47	3779-3789	dependence	_
22-48	3790-3791	(	_
22-49	3792-3798	within	_
22-50	3799-3802	the	_
22-51	3803-3807	past	_
22-52	3808-3809	3	_
22-53	3810-3816	months	_
22-54	3817-3818	)	_
22-55	3819-3820	;	_
22-56	3821-3822	(	_
22-57	3823-3824	4	_
22-58	3825-3826	)	_
22-59	3827-3830	any	_
22-60	3831-3834	MRI	_
22-61	3835-3852	contraindications	_
22-62	3853-3856	and	_
22-63	3857-3858	(	_
22-64	3859-3860	5	_
22-65	3861-3862	)	_
22-66	3863-3873	decisional	_
22-67	3874-3884	incapacity	_
22-68	3885-3894	requiring	_
22-69	3895-3896	a	_
22-70	3897-3905	guardian	_
22-71	3906-3907	.	_

Text=Demographic, clinical, and medication regimen information are summarized in Supplemental Table 1.
23-1	3908-3919	Demographic	_
23-2	3920-3921	,	_
23-3	3922-3930	clinical	_
23-4	3931-3932	,	_
23-5	3933-3936	and	_
23-6	3937-3947	medication	_
23-7	3948-3955	regimen	_
23-8	3956-3967	information	_
23-9	3968-3971	are	_
23-10	3972-3982	summarized	_
23-11	3983-3985	in	_
23-12	3986-3998	Supplemental	_
23-13	3999-4004	Table	_
23-14	4005-4006	1	_
23-15	4007-4008	.	_

Text=Cognitive Testing Participant emotional intelligence was assessed using the MATRICS Consensus Cognitive Battery (MCCB).
24-1	4009-4018	Cognitive	_
24-2	4019-4026	Testing	_
24-3	4027-4038	Participant	_
24-4	4039-4048	emotional	_
24-5	4049-4061	intelligence	_
24-6	4062-4065	was	_
24-7	4066-4074	assessed	_
24-8	4075-4080	using	_
24-9	4081-4084	the	_
24-10	4085-4092	MATRICS	http://maven.renci.org/NeuroBridge/neurobridge#CognitiveDisorder
24-11	4093-4102	Consensus	http://maven.renci.org/NeuroBridge/neurobridge#CognitiveDisorder
24-12	4103-4112	Cognitive	http://maven.renci.org/NeuroBridge/neurobridge#CognitiveDisorder
24-13	4113-4120	Battery	http://maven.renci.org/NeuroBridge/neurobridge#CognitiveDisorder
24-14	4121-4122	(	http://maven.renci.org/NeuroBridge/neurobridge#CognitiveDisorder
24-15	4123-4127	MCCB	http://maven.renci.org/NeuroBridge/neurobridge#CognitiveDisorder
24-16	4128-4129	)	http://maven.renci.org/NeuroBridge/neurobridge#CognitiveDisorder
24-17	4130-4131	.	_

Text=This testing battery includes 7 composite scores of processing speed, attention, working memory, verbal learning, visual learning, problem solving, and social cognition.
25-1	4132-4136	This	_
25-2	4137-4144	testing	_
25-3	4145-4152	battery	_
25-4	4153-4161	includes	_
25-5	4162-4163	7	_
25-6	4164-4173	composite	_
25-7	4174-4180	scores	_
25-8	4181-4183	of	_
25-9	4184-4194	processing	_
25-10	4195-4200	speed	_
25-11	4201-4202	,	_
25-12	4203-4212	attention	_
25-13	4213-4214	,	_
25-14	4215-4222	working	_
25-15	4223-4229	memory	_
25-16	4230-4231	,	_
25-17	4232-4238	verbal	_
25-18	4239-4247	learning	_
25-19	4248-4249	,	_
25-20	4250-4256	visual	_
25-21	4257-4265	learning	_
25-22	4266-4267	,	_
25-23	4268-4275	problem	_
25-24	4276-4283	solving	_
25-25	4284-4285	,	_
25-26	4286-4289	and	_
25-27	4290-4296	social	_
25-28	4297-4306	cognition	_
25-29	4307-4308	.	_

Text=The social cognition score is calculated from the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT) “ managing emotions ” subscale.
26-1	4309-4312	The	_
26-2	4313-4319	social	_
26-3	4320-4329	cognition	_
26-4	4330-4335	score	_
26-5	4336-4338	is	_
26-6	4339-4349	calculated	_
26-7	4350-4354	from	_
26-8	4355-4358	the	_
26-9	4359-4379	Mayer-Salovey-Caruso	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
26-10	4380-4389	Emotional	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
26-11	4390-4402	Intelligence	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
26-12	4403-4407	Test	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
26-13	4408-4409	(	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
26-14	4410-4416	MSCEIT	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
26-15	4417-4418	)	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
26-16	4419-4420	“	_
26-17	4421-4429	managing	_
26-18	4430-4438	emotions	_
26-19	4439-4440	”	_
26-20	4441-4449	subscale	_
26-21	4450-4451	.	_

Text=The MSCEIT includes a series of vignettes.
27-1	4452-4455	The	_
27-2	4456-4462	MSCEIT	_
27-3	4463-4471	includes	_
27-4	4472-4473	a	_
27-5	4474-4480	series	_
27-6	4481-4483	of	_
27-7	4484-4493	vignettes	_
27-8	4494-4495	.	_

Text=Participants are presented with a series of possible actions related to each vignette and asked to assess the effects of each action on the actor ’ s or other characters ’ mood states or behaviors.
28-1	4496-4508	Participants	_
28-2	4509-4512	are	_
28-3	4513-4522	presented	_
28-4	4523-4527	with	_
28-5	4528-4529	a	_
28-6	4530-4536	series	_
28-7	4537-4539	of	_
28-8	4540-4548	possible	_
28-9	4549-4556	actions	_
28-10	4557-4564	related	_
28-11	4565-4567	to	_
28-12	4568-4572	each	_
28-13	4573-4581	vignette	_
28-14	4582-4585	and	_
28-15	4586-4591	asked	_
28-16	4592-4594	to	_
28-17	4595-4601	assess	_
28-18	4602-4605	the	_
28-19	4606-4613	effects	_
28-20	4614-4616	of	_
28-21	4617-4621	each	_
28-22	4622-4628	action	_
28-23	4629-4631	on	_
28-24	4632-4635	the	_
28-25	4636-4641	actor	_
28-26	4642-4643	’	_
28-27	4644-4645	s	_
28-28	4646-4648	or	_
28-29	4649-4654	other	_
28-30	4655-4665	characters	_
28-31	4666-4667	’	_
28-32	4668-4672	mood	_
28-33	4673-4679	states	_
28-34	4680-4682	or	_
28-35	4683-4692	behaviors	_
28-36	4693-4694	.	_

Text=Responses are based on a Likert-type scale.
29-1	4695-4704	Responses	_
29-2	4705-4708	are	_
29-3	4709-4714	based	_
29-4	4715-4717	on	_
29-5	4718-4719	a	_
29-6	4720-4731	Likert-type	_
29-7	4732-4737	scale	_
29-8	4738-4739	.	_

Text=We used age and sex normed T scores, which were calculated using the MCCB scoring package.
30-1	4740-4742	We	_
30-2	4743-4747	used	_
30-3	4748-4751	age	_
30-4	4752-4755	and	_
30-5	4756-4759	sex	_
30-6	4760-4766	normed	_
30-7	4767-4768	T	_
30-8	4769-4775	scores	_
30-9	4776-4777	,	_
30-10	4778-4783	which	_
30-11	4784-4788	were	_
30-12	4789-4799	calculated	_
30-13	4800-4805	using	_
30-14	4806-4809	the	_
30-15	4810-4814	MCCB	_
30-16	4815-4822	scoring	_
30-17	4823-4830	package	_
30-18	4831-4832	.	_

Text=MRI data acquisition Boston & Belmont sites Data were acquired on 3T Siemens Trio (TIM upgrade) scanners using a standard head coil.
31-1	4833-4836	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
31-2	4837-4841	data	_
31-3	4842-4853	acquisition	_
31-4	4854-4860	Boston	_
31-5	4861-4862	&	_
31-6	4863-4870	Belmont	_
31-7	4871-4876	sites	_
31-8	4877-4881	Data	_
31-9	4882-4886	were	_
31-10	4887-4895	acquired	_
31-11	4896-4898	on	_
31-12	4899-4901	3T	_
31-13	4902-4909	Siemens	_
31-14	4910-4914	Trio	_
31-15	4915-4916	(	_
31-16	4917-4920	TIM	_
31-17	4921-4928	upgrade	_
31-18	4929-4930	)	_
31-19	4931-4939	scanners	_
31-20	4940-4945	using	_
31-21	4946-4947	a	_
31-22	4948-4956	standard	_
31-23	4957-4961	head	_
31-24	4962-4966	coil	_
31-25	4967-4968	.	_

Text=The echoplanar imaging parameters were as follows: repetition time, 3000 milliseconds; echo time, 30 milliseconds; flip angle, 85°; 3 × 3 × 3-mm voxels; and 47 axial sections collected with interleaved acquisition and no gap.
32-1	4969-4972	The	_
32-2	4973-4983	echoplanar	_
32-3	4984-4991	imaging	_
32-4	4992-5002	parameters	_
32-5	5003-5007	were	_
32-6	5008-5010	as	_
32-7	5011-5018	follows	_
32-8	5019-5020	:	_
32-9	5021-5031	repetition	_
32-10	5032-5036	time	_
32-11	5037-5038	,	_
32-12	5039-5043	3000	_
32-13	5044-5056	milliseconds	_
32-14	5057-5058	;	_
32-15	5059-5063	echo	_
32-16	5064-5068	time	_
32-17	5069-5070	,	_
32-18	5071-5073	30	_
32-19	5074-5086	milliseconds	_
32-20	5087-5088	;	_
32-21	5089-5093	flip	_
32-22	5094-5099	angle	_
32-23	5100-5101	,	_
32-24	5102-5105	85°	_
32-25	5106-5107	;	_
32-26	5108-5109	3	_
32-27	5110-5111	×	_
32-28	5112-5113	3	_
32-29	5114-5115	×	_
32-30	5116-5120	3-mm	_
32-31	5121-5127	voxels	_
32-32	5128-5129	;	_
32-33	5130-5133	and	_
32-34	5134-5136	47	_
32-35	5137-5142	axial	_
32-36	5143-5151	sections	_
32-37	5152-5161	collected	_
32-38	5162-5166	with	_
32-39	5167-5178	interleaved	_
32-40	5179-5190	acquisition	_
32-41	5191-5194	and	_
32-42	5195-5197	no	_
32-43	5198-5201	gap	_
32-44	5202-5203	.	_

Text=Structural data included a high-resolution T1 image.
33-1	5204-5214	Structural	_
33-2	5215-5219	data	_
33-3	5220-5228	included	_
33-4	5229-5230	a	_
33-5	5231-5246	high-resolution	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
33-6	5247-5249	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
33-7	5250-5255	image	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
33-8	5256-5257	.	_

Text=In addition, all participants underwent a resting fMRI run with the instructions ‘ remain still, stay awake, and keep your eyes open ’.
34-1	5258-5260	In	_
34-2	5261-5269	addition	_
34-3	5270-5271	,	_
34-4	5272-5275	all	_
34-5	5276-5288	participants	_
34-6	5289-5298	underwent	_
34-7	5299-5300	a	_
34-8	5301-5308	resting	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
34-9	5309-5313	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
34-10	5314-5317	run	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
34-11	5318-5322	with	_
34-12	5323-5326	the	_
34-13	5327-5339	instructions	_
34-14	5340-5341	‘	_
34-15	5342-5348	remain	_
34-16	5349-5354	still	_
34-17	5355-5356	,	_
34-18	5357-5361	stay	_
34-19	5362-5367	awake	_
34-20	5368-5369	,	_
34-21	5370-5373	and	_
34-22	5374-5378	keep	_
34-23	5379-5383	your	_
34-24	5384-5388	eyes	_
34-25	5389-5393	open	_
34-26	5394-5395	’	_
34-27	5396-5397	.	_

Text=Each functional run lasted 6.2 minutes (124 time points).
35-1	5398-5402	Each	_
35-2	5403-5413	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
35-3	5414-5417	run	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
35-4	5418-5424	lasted	_
35-5	5425-5428	6.2	_
35-6	5429-5436	minutes	_
35-7	5437-5438	(	_
35-8	5439-5442	124	_
35-9	5443-5447	time	_
35-10	5448-5454	points	_
35-11	5455-5456	)	_
35-12	5457-5458	.	_

Text=Pittsburgh site Data were acquired on a 3T Siemens Verio scanner using a standard head coil.
36-1	5459-5469	Pittsburgh	_
36-2	5470-5474	site	_
36-3	5475-5479	Data	_
36-4	5480-5484	were	_
36-5	5485-5493	acquired	_
36-6	5494-5496	on	_
36-7	5497-5498	a	_
36-8	5499-5501	3T	_
36-9	5502-5509	Siemens	_
36-10	5510-5515	Verio	_
36-11	5516-5523	scanner	_
36-12	5524-5529	using	_
36-13	5530-5531	a	_
36-14	5532-5540	standard	_
36-15	5541-5545	head	_
36-16	5546-5550	coil	_
36-17	5551-5552	.	_

Text=The echoplanar imaging parameters were as follows: repetition time, 3000 milliseconds; echo time, 30 milliseconds; flip angle, 85°; 3 × 3 × 3-mm voxels; and 45 axial sections collected with interleaved acquisition and no gap.
37-1	5553-5556	The	_
37-2	5557-5567	echoplanar	_
37-3	5568-5575	imaging	_
37-4	5576-5586	parameters	_
37-5	5587-5591	were	_
37-6	5592-5594	as	_
37-7	5595-5602	follows	_
37-8	5603-5604	:	_
37-9	5605-5615	repetition	_
37-10	5616-5620	time	_
37-11	5621-5622	,	_
37-12	5623-5627	3000	_
37-13	5628-5640	milliseconds	_
37-14	5641-5642	;	_
37-15	5643-5647	echo	_
37-16	5648-5652	time	_
37-17	5653-5654	,	_
37-18	5655-5657	30	_
37-19	5658-5670	milliseconds	_
37-20	5671-5672	;	_
37-21	5673-5677	flip	_
37-22	5678-5683	angle	_
37-23	5684-5685	,	_
37-24	5686-5689	85°	_
37-25	5690-5691	;	_
37-26	5692-5693	3	_
37-27	5694-5695	×	_
37-28	5696-5697	3	_
37-29	5698-5699	×	_
37-30	5700-5704	3-mm	_
37-31	5705-5711	voxels	_
37-32	5712-5713	;	_
37-33	5714-5717	and	_
37-34	5718-5720	45	_
37-35	5721-5726	axial	_
37-36	5727-5735	sections	_
37-37	5736-5745	collected	_
37-38	5746-5750	with	_
37-39	5751-5762	interleaved	_
37-40	5763-5774	acquisition	_
37-41	5775-5778	and	_
37-42	5779-5781	no	_
37-43	5782-5785	gap	_
37-44	5786-5787	.	_

Text=Structural data included a high-resolution T1 image.
38-1	5788-5798	Structural	_
38-2	5799-5803	data	_
38-3	5804-5812	included	_
38-4	5813-5814	a	_
38-5	5815-5830	high-resolution	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
38-6	5831-5833	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
38-7	5834-5839	image	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
38-8	5840-5841	.	_

Text=In addition, all participants underwent a resting fMRI run that lasted 6.2 minutes (124 time points).
39-1	5842-5844	In	_
39-2	5845-5853	addition	_
39-3	5854-5855	,	_
39-4	5856-5859	all	_
39-5	5860-5872	participants	_
39-6	5873-5882	underwent	_
39-7	5883-5884	a	_
39-8	5885-5892	resting	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
39-9	5893-5897	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
39-10	5898-5901	run	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
39-11	5902-5906	that	_
39-12	5907-5913	lasted	_
39-13	5914-5917	6.2	_
39-14	5918-5925	minutes	_
39-15	5926-5927	(	_
39-16	5928-5931	124	_
39-17	5932-5936	time	_
39-18	5937-5943	points	_
39-19	5944-5945	)	_
39-20	5946-5947	.	_

Text=MRI data processing The imaging data was preprocessed using DPABI image processing software.
40-1	5948-5951	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
40-2	5952-5956	data	_
40-3	5957-5967	processing	_
40-4	5968-5971	The	_
40-5	5972-5979	imaging	_
40-6	5980-5984	data	_
40-7	5985-5988	was	_
40-8	5989-6001	preprocessed	_
40-9	6002-6007	using	_
40-10	6008-6013	DPABI	_
40-11	6014-6019	image	_
40-12	6020-6030	processing	_
40-13	6031-6039	software	_
40-14	6040-6041	.	_

Text=To minimize effects of scanner signal stabilization, the first four images were omitted from all analysis.
41-1	6042-6044	To	_
41-2	6045-6053	minimize	_
41-3	6054-6061	effects	_
41-4	6062-6064	of	_
41-5	6065-6072	scanner	_
41-6	6073-6079	signal	_
41-7	6080-6093	stabilization	_
41-8	6094-6095	,	_
41-9	6096-6099	the	_
41-10	6100-6105	first	_
41-11	6106-6110	four	_
41-12	6111-6117	images	_
41-13	6118-6122	were	_
41-14	6123-6130	omitted	_
41-15	6131-6135	from	_
41-16	6136-6139	all	_
41-17	6140-6148	analysis	_
41-18	6149-6150	.	_

Text=Scans with head motion exceeding 3 mm or 3° of maximum rotation through the resting-state run were discarded (n = 28).
42-1	6151-6156	Scans	_
42-2	6157-6161	with	_
42-3	6162-6166	head	_
42-4	6167-6173	motion	_
42-5	6174-6183	exceeding	_
42-6	6184-6185	3	_
42-7	6186-6188	mm	_
42-8	6189-6191	or	_
42-9	6192-6194	3°	_
42-10	6195-6197	of	_
42-11	6198-6205	maximum	_
42-12	6206-6214	rotation	_
42-13	6215-6222	through	_
42-14	6223-6226	the	_
42-15	6227-6240	resting-state	_
42-16	6241-6244	run	_
42-17	6245-6249	were	_
42-18	6250-6259	discarded	_
42-19	6260-6261	(	_
42-20	6262-6263	n	_
42-21	6264-6265	=	_
42-22	6266-6268	28	_
42-23	6269-6270	)	_
42-24	6271-6272	.	_

Text=Functional and structural images were co-registered.
43-1	6273-6283	Functional	_
43-2	6284-6287	and	_
43-3	6288-6298	structural	_
43-4	6299-6305	images	_
43-5	6306-6310	were	_
43-6	6311-6324	co-registered	_
43-7	6325-6326	.	_

Text=Structural images were then normalized and segmented into gray, white and CSF partitions using the DARTEL technique.
44-1	6327-6337	Structural	_
44-2	6338-6344	images	_
44-3	6345-6349	were	_
44-4	6350-6354	then	_
44-5	6355-6365	normalized	_
44-6	6366-6369	and	_
44-7	6370-6379	segmented	_
44-8	6380-6384	into	_
44-9	6385-6389	gray	_
44-10	6390-6391	,	_
44-11	6392-6397	white	_
44-12	6398-6401	and	_
44-13	6402-6405	CSF	_
44-14	6406-6416	partitions	_
44-15	6417-6422	using	_
44-16	6423-6426	the	_
44-17	6427-6433	DARTEL	_
44-18	6434-6443	technique	_
44-19	6444-6445	.	_

Text=A Friston 24-parameter model was used to regress out head motion effects from the realigned data.
45-1	6446-6447	A	_
45-2	6448-6455	Friston	_
45-3	6456-6468	24-parameter	_
45-4	6469-6474	model	_
45-5	6475-6478	was	_
45-6	6479-6483	used	_
45-7	6484-6486	to	_
45-8	6487-6494	regress	_
45-9	6495-6498	out	_
45-10	6499-6503	head	_
45-11	6504-6510	motion	_
45-12	6511-6518	effects	_
45-13	6519-6523	from	_
45-14	6524-6527	the	_
45-15	6528-6537	realigned	_
45-16	6538-6542	data	_
45-17	6543-6544	.	_

Text=CSF and white matter signals, global signal as well as the linear trend were also regressed out.
46-1	6545-6548	CSF	_
46-2	6549-6552	and	_
46-3	6553-6558	white	_
46-4	6559-6565	matter	_
46-5	6566-6573	signals	_
46-6	6574-6575	,	_
46-7	6576-6582	global	_
46-8	6583-6589	signal	_
46-9	6590-6592	as	_
46-10	6593-6597	well	_
46-11	6598-6600	as	_
46-12	6601-6604	the	_
46-13	6605-6611	linear	_
46-14	6612-6617	trend	_
46-15	6618-6622	were	_
46-16	6623-6627	also	_
46-17	6628-6637	regressed	_
46-18	6638-6641	out	_
46-19	6642-6643	.	_

Text=The decision to regress the global signal was based on prior demonstration that the combination of this step plus volume-wise ‘ scrubbing ’ for head ‘ micromovements ’ is an effective strategy for removal of motion artifacts.
47-1	6644-6647	The	_
47-2	6648-6656	decision	_
47-3	6657-6659	to	_
47-4	6660-6667	regress	_
47-5	6668-6671	the	_
47-6	6672-6678	global	_
47-7	6679-6685	signal	_
47-8	6686-6689	was	_
47-9	6690-6695	based	_
47-10	6696-6698	on	_
47-11	6699-6704	prior	_
47-12	6705-6718	demonstration	_
47-13	6719-6723	that	_
47-14	6724-6727	the	_
47-15	6728-6739	combination	_
47-16	6740-6742	of	_
47-17	6743-6747	this	_
47-18	6748-6752	step	_
47-19	6753-6757	plus	_
47-20	6758-6769	volume-wise	_
47-21	6770-6771	‘	_
47-22	6772-6781	scrubbing	_
47-23	6782-6783	’	_
47-24	6784-6787	for	_
47-25	6788-6792	head	_
47-26	6793-6794	‘	_
47-27	6795-6809	micromovements	_
47-28	6810-6811	’	_
47-29	6812-6814	is	_
47-30	6815-6817	an	_
47-31	6818-6827	effective	_
47-32	6828-6836	strategy	_
47-33	6837-6840	for	_
47-34	6841-6848	removal	_
47-35	6849-6851	of	_
47-36	6852-6858	motion	_
47-37	6859-6868	artifacts	_
47-38	6869-6870	.	_

Text=After realigning, slice timing correction, and co-registration, framewise displacement (FD) was calculated for all resting state volumes.
48-1	6871-6876	After	_
48-2	6877-6887	realigning	_
48-3	6888-6889	,	_
48-4	6890-6895	slice	_
48-5	6896-6902	timing	_
48-6	6903-6913	correction	_
48-7	6914-6915	,	_
48-8	6916-6919	and	_
48-9	6920-6935	co-registration	_
48-10	6936-6937	,	_
48-11	6938-6947	framewise	_
48-12	6948-6960	displacement	_
48-13	6961-6962	(	_
48-14	6963-6965	FD	_
48-15	6966-6967	)	_
48-16	6968-6971	was	_
48-17	6972-6982	calculated	_
48-18	6983-6986	for	_
48-19	6987-6990	all	_
48-20	6991-6998	resting	_
48-21	6999-7004	state	_
48-22	7005-7012	volumes	_
48-23	7013-7014	.	_

Text=All volumes within a scan with a FD greater than 0.2-mm were censored.
49-1	7015-7018	All	_
49-2	7019-7026	volumes	_
49-3	7027-7033	within	_
49-4	7034-7035	a	_
49-5	7036-7040	scan	_
49-6	7041-7045	with	_
49-7	7046-7047	a	_
49-8	7048-7050	FD	_
49-9	7051-7058	greater	_
49-10	7059-7063	than	_
49-11	7064-7070	0.2-mm	_
49-12	7071-7075	were	_
49-13	7076-7084	censored	_
49-14	7085-7086	.	_

Text=Any scan with at least 50% of volumes requiring censoring was discarded (n = 18).
50-1	7087-7090	Any	_
50-2	7091-7095	scan	_
50-3	7096-7100	with	_
50-4	7101-7103	at	_
50-5	7104-7109	least	_
50-6	7110-7112	50	_
50-7	7113-7114	%	_
50-8	7115-7117	of	_
50-9	7118-7125	volumes	_
50-10	7126-7135	requiring	_
50-11	7136-7145	censoring	_
50-12	7146-7149	was	_
50-13	7150-7159	discarded	_
50-14	7160-7161	(	_
50-15	7162-7163	n	_
50-16	7164-7165	=	_
50-17	7166-7168	18	_
50-18	7169-7170	)	_
50-19	7171-7172	.	_

Text=After nuisance covariate regression, the resultant data were band-pass filtered to select low frequency (0.01 – 0.08Hz) signals.
51-1	7173-7178	After	_
51-2	7179-7187	nuisance	_
51-3	7188-7197	covariate	_
51-4	7198-7208	regression	_
51-5	7209-7210	,	_
51-6	7211-7214	the	_
51-7	7215-7224	resultant	_
51-8	7225-7229	data	_
51-9	7230-7234	were	_
51-10	7235-7244	band-pass	_
51-11	7245-7253	filtered	_
51-12	7254-7256	to	_
51-13	7257-7263	select	_
51-14	7264-7267	low	_
51-15	7268-7277	frequency	_
51-16	7278-7279	(	_
51-17	7280-7284	0.01	_
51-18	7285-7286	–	_
51-19	7287-7293	0.08Hz	_
51-20	7294-7295	)	_
51-21	7296-7303	signals	_
51-22	7304-7305	.	_

Text=Filtered data were normalized by DARTEL into MNI space and then smoothed by a Gaussian kernel of 8mm3 full-width at half maximum (FWHM).
52-1	7306-7314	Filtered	_
52-2	7315-7319	data	_
52-3	7320-7324	were	_
52-4	7325-7335	normalized	_
52-5	7336-7338	by	_
52-6	7339-7345	DARTEL	_
52-7	7346-7350	into	_
52-8	7351-7354	MNI	_
52-9	7355-7360	space	_
52-10	7361-7364	and	_
52-11	7365-7369	then	_
52-12	7370-7378	smoothed	_
52-13	7379-7381	by	_
52-14	7382-7383	a	_
52-15	7384-7392	Gaussian	_
52-16	7393-7399	kernel	_
52-17	7400-7402	of	_
52-18	7403-7407	8mm3	_
52-19	7408-7418	full-width	_
52-20	7419-7421	at	_
52-21	7422-7426	half	_
52-22	7427-7434	maximum	_
52-23	7435-7436	(	_
52-24	7437-7441	FWHM	_
52-25	7442-7443	)	_
52-26	7444-7445	.	_

Text=Voxels within a group derived gray matter mask were used for further analyses.
53-1	7446-7452	Voxels	_
53-2	7453-7459	within	_
53-3	7460-7461	a	_
53-4	7462-7467	group	_
53-5	7468-7475	derived	_
53-6	7476-7480	gray	_
53-7	7481-7487	matter	_
53-8	7488-7492	mask	_
53-9	7493-7497	were	_
53-10	7498-7502	used	_
53-11	7503-7506	for	_
53-12	7507-7514	further	_
53-13	7515-7523	analyses	_
53-14	7524-7525	.	_

Text=After preprocessing, a total of 60 participants with schizophrenia or schizoaffective disorder, and 45 HC participants across all sites remained in the study (Supplemental Table 1).
54-1	7526-7531	After	_
54-2	7532-7545	preprocessing	_
54-3	7546-7547	,	_
54-4	7548-7549	a	_
54-5	7550-7555	total	_
54-6	7556-7558	of	_
54-7	7559-7561	60	_
54-8	7562-7574	participants	http://maven.renci.org/NeuroBridge/neurobridge#SchizoaffectiveDisorder
54-9	7575-7579	with	http://maven.renci.org/NeuroBridge/neurobridge#SchizoaffectiveDisorder
54-10	7580-7593	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#SchizoaffectiveDisorder
54-11	7594-7596	or	http://maven.renci.org/NeuroBridge/neurobridge#SchizoaffectiveDisorder
54-12	7597-7612	schizoaffective	http://maven.renci.org/NeuroBridge/neurobridge#SchizoaffectiveDisorder
54-13	7613-7621	disorder	http://maven.renci.org/NeuroBridge/neurobridge#SchizoaffectiveDisorder
54-14	7622-7623	,	_
54-15	7624-7627	and	_
54-16	7628-7630	45	_
54-17	7631-7633	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
54-18	7634-7646	participants	_
54-19	7647-7653	across	_
54-20	7654-7657	all	_
54-21	7658-7663	sites	_
54-22	7664-7672	remained	_
54-23	7673-7675	in	_
54-24	7676-7679	the	_
54-25	7680-7685	study	_
54-26	7686-7687	(	_
54-27	7688-7700	Supplemental	_
54-28	7701-7706	Table	_
54-29	7707-7708	1	_
54-30	7709-7710	)	_
54-31	7711-7712	.	_

Text=Functional Connectivity Analysis Multivariate Distance Matrix Regression We performed a connectome-wide association study using multivariate distance matrix regression (MDMR) as originally described in.
55-1	7713-7723	Functional	_
55-2	7724-7736	Connectivity	_
55-3	7737-7745	Analysis	_
55-4	7746-7758	Multivariate	_
55-5	7759-7767	Distance	_
55-6	7768-7774	Matrix	_
55-7	7775-7785	Regression	_
55-8	7786-7788	We	_
55-9	7789-7798	performed	_
55-10	7799-7800	a	_
55-11	7801-7816	connectome-wide	_
55-12	7817-7828	association	_
55-13	7829-7834	study	_
55-14	7835-7840	using	_
55-15	7841-7853	multivariate	_
55-16	7854-7862	distance	_
55-17	7863-7869	matrix	_
55-18	7870-7880	regression	_
55-19	7881-7882	(	_
55-20	7883-7887	MDMR	_
55-21	7888-7889	)	_
55-22	7890-7892	as	_
55-23	7893-7903	originally	_
55-24	7904-7913	described	_
55-25	7914-7916	in	_
55-26	7917-7918	.	_

Text=Briefly, MDMR tests every voxel to determine if whole-brain connectivity to that voxel is more similar in individuals with similar MSCEIT score than in individuals with dissimilar MSCEIT score.
56-1	7919-7926	Briefly	_
56-2	7927-7928	,	_
56-3	7929-7933	MDMR	http://maven.renci.org/NeuroBridge/neurobridge#Thing
56-4	7934-7939	tests	_
56-5	7940-7945	every	_
56-6	7946-7951	voxel	_
56-7	7952-7954	to	_
56-8	7955-7964	determine	_
56-9	7965-7967	if	_
56-10	7968-7979	whole-brain	_
56-11	7980-7992	connectivity	_
56-12	7993-7995	to	_
56-13	7996-8000	that	_
56-14	8001-8006	voxel	_
56-15	8007-8009	is	_
56-16	8010-8014	more	_
56-17	8015-8022	similar	_
56-18	8023-8025	in	_
56-19	8026-8037	individuals	_
56-20	8038-8042	with	_
56-21	8043-8050	similar	_
56-22	8051-8057	MSCEIT	_
56-23	8058-8063	score	_
56-24	8064-8068	than	_
56-25	8069-8071	in	_
56-26	8072-8083	individuals	_
56-27	8084-8088	with	_
56-28	8089-8099	dissimilar	_
56-29	8100-8106	MSCEIT	_
56-30	8107-8112	score	_
56-31	8113-8114	.	_

Text=As previously described, this analysis occurs in several stages: First, a seed-to-voxel connectivity map is generated by using an individual voxel ’ s BOLD signal time-course to calculate the temporal Pearson ’ s correlation coefficients between that voxel and all other gray matter voxels (Figure 1B).
57-1	8115-8117	As	_
57-2	8118-8128	previously	_
57-3	8129-8138	described	_
57-4	8139-8140	,	_
57-5	8141-8145	this	_
57-6	8146-8154	analysis	_
57-7	8155-8161	occurs	_
57-8	8162-8164	in	_
57-9	8165-8172	several	_
57-10	8173-8179	stages	_
57-11	8180-8181	:	_
57-12	8182-8187	First	_
57-13	8188-8189	,	_
57-14	8190-8191	a	_
57-15	8192-8205	seed-to-voxel	_
57-16	8206-8218	connectivity	_
57-17	8219-8222	map	_
57-18	8223-8225	is	_
57-19	8226-8235	generated	_
57-20	8236-8238	by	_
57-21	8239-8244	using	_
57-22	8245-8247	an	_
57-23	8248-8258	individual	_
57-24	8259-8264	voxel	_
57-25	8265-8266	’	_
57-26	8267-8268	s	_
57-27	8269-8273	BOLD	_
57-28	8274-8280	signal	_
57-29	8281-8292	time-course	_
57-30	8293-8295	to	_
57-31	8296-8305	calculate	_
57-32	8306-8309	the	_
57-33	8310-8318	temporal	_
57-34	8319-8326	Pearson	_
57-35	8327-8328	’	_
57-36	8329-8330	s	_
57-37	8331-8342	correlation	_
57-38	8343-8355	coefficients	_
57-39	8356-8363	between	_
57-40	8364-8368	that	_
57-41	8369-8374	voxel	_
57-42	8375-8378	and	_
57-43	8379-8382	all	_
57-44	8383-8388	other	_
57-45	8389-8393	gray	_
57-46	8394-8400	matter	_
57-47	8401-8407	voxels	_
57-48	8408-8409	(	_
57-49	8410-8416	Figure	_
57-50	8417-8419	1B	_
57-51	8420-8421	)	_
57-52	8422-8423	.	_

Text=These maps are generated for every participant.
58-1	8424-8429	These	_
58-2	8430-8434	maps	_
58-3	8435-8438	are	_
58-4	8439-8448	generated	_
58-5	8449-8452	for	_
58-6	8453-8458	every	_
58-7	8459-8470	participant	_
58-8	8471-8472	.	_

Text=In the second stage, the temporal correlation coefficients for each voxel in the connectivity map is correlated with the values of corresponding voxels in maps generated from every other participant.
59-1	8473-8475	In	_
59-2	8476-8479	the	_
59-3	8480-8486	second	_
59-4	8487-8492	stage	_
59-5	8493-8494	,	_
59-6	8495-8498	the	_
59-7	8499-8507	temporal	_
59-8	8508-8519	correlation	_
59-9	8520-8532	coefficients	_
59-10	8533-8536	for	_
59-11	8537-8541	each	_
59-12	8542-8547	voxel	_
59-13	8548-8550	in	_
59-14	8551-8554	the	_
59-15	8555-8567	connectivity	_
59-16	8568-8571	map	_
59-17	8572-8574	is	_
59-18	8575-8585	correlated	_
59-19	8586-8590	with	_
59-20	8591-8594	the	_
59-21	8595-8601	values	_
59-22	8602-8604	of	_
59-23	8605-8618	corresponding	_
59-24	8619-8625	voxels	_
59-25	8626-8628	in	_
59-26	8629-8633	maps	_
59-27	8634-8643	generated	_
59-28	8644-8648	from	_
59-29	8649-8654	every	_
59-30	8655-8660	other	_
59-31	8661-8672	participant	_
59-32	8673-8674	.	_

Text=This Pearson ’ s correlation coefficient, r is a measure of the similarity of whole-brain connectivity to that voxel between patients.
60-1	8675-8679	This	_
60-2	8680-8687	Pearson	_
60-3	8688-8689	’	_
60-4	8690-8691	s	_
60-5	8692-8703	correlation	_
60-6	8704-8715	coefficient	_
60-7	8716-8717	,	_
60-8	8718-8719	r	_
60-9	8720-8722	is	_
60-10	8723-8724	a	_
60-11	8725-8732	measure	_
60-12	8733-8735	of	_
60-13	8736-8739	the	_
60-14	8740-8750	similarity	_
60-15	8751-8753	of	_
60-16	8754-8765	whole-brain	_
60-17	8766-8778	connectivity	_
60-18	8779-8781	to	_
60-19	8782-8786	that	_
60-20	8787-8792	voxel	_
60-21	8793-8800	between	_
60-22	8801-8809	patients	_
60-23	8810-8811	.	_

Text=This value is used to calculate between-subject distance (or dissimilarity) using the metric where i and j are two subjects and r is the correlation coefficient above.
61-1	8812-8816	This	_
61-2	8817-8822	value	_
61-3	8823-8825	is	_
61-4	8826-8830	used	_
61-5	8831-8833	to	_
61-6	8834-8843	calculate	_
61-7	8844-8859	between-subject	_
61-8	8860-8868	distance	_
61-9	8869-8870	(	_
61-10	8871-8873	or	_
61-11	8874-8887	dissimilarity	_
61-12	8888-8889	)	_
61-13	8890-8895	using	_
61-14	8896-8899	the	_
61-15	8900-8906	metric	_
61-16	8907-8912	where	_
61-17	8913-8914	i	_
61-18	8915-8918	and	_
61-19	8919-8920	j	_
61-20	8921-8924	are	_
61-21	8925-8928	two	_
61-22	8929-8937	subjects	_
61-23	8938-8941	and	_
61-24	8942-8943	r	_
61-25	8944-8946	is	_
61-26	8947-8950	the	_
61-27	8951-8962	correlation	_
61-28	8963-8974	coefficient	_
61-29	8975-8980	above	_
61-30	8981-8982	.	_

Text=(Figure 1C).
62-1	8983-8984	(	_
62-2	8985-8991	Figure	_
62-3	8992-8994	1C	_
62-4	8995-8996	)	_
62-5	8997-8998	.	_

Text=The next stage tests the relationship between a given variable (here MSCEIT score) and the inter-subject distances in connectivity generated in the previous stage.
63-1	8999-9002	The	_
63-2	9003-9007	next	_
63-3	9008-9013	stage	_
63-4	9014-9019	tests	_
63-5	9020-9023	the	_
63-6	9024-9036	relationship	_
63-7	9037-9044	between	_
63-8	9045-9046	a	_
63-9	9047-9052	given	_
63-10	9053-9061	variable	_
63-11	9062-9063	(	_
63-12	9064-9068	here	_
63-13	9069-9075	MSCEIT	_
63-14	9076-9081	score	_
63-15	9082-9083	)	_
63-16	9084-9087	and	_
63-17	9088-9091	the	_
63-18	9092-9105	inter-subject	_
63-19	9106-9115	distances	_
63-20	9116-9118	in	_
63-21	9119-9131	connectivity	_
63-22	9132-9141	generated	_
63-23	9142-9144	in	_
63-24	9145-9148	the	_
63-25	9149-9157	previous	_
63-26	9158-9163	stage	_
63-27	9164-9165	.	_

Text=Broadly speaking, this process consists of ANOVA-like hypothesis testing where the tested relationship is between a variable of interest and a matrix of distances.
64-1	9166-9173	Broadly	_
64-2	9174-9182	speaking	_
64-3	9183-9184	,	_
64-4	9185-9189	this	_
64-5	9190-9197	process	_
64-6	9198-9206	consists	_
64-7	9207-9209	of	_
64-8	9210-9220	ANOVA-like	_
64-9	9221-9231	hypothesis	_
64-10	9232-9239	testing	_
64-11	9240-9245	where	_
64-12	9246-9249	the	_
64-13	9250-9256	tested	_
64-14	9257-9269	relationship	_
64-15	9270-9272	is	_
64-16	9273-9280	between	_
64-17	9281-9282	a	_
64-18	9283-9291	variable	_
64-19	9292-9294	of	_
64-20	9295-9303	interest	_
64-21	9304-9307	and	_
64-22	9308-9309	a	_
64-23	9310-9316	matrix	_
64-24	9317-9319	of	_
64-25	9320-9329	distances	_
64-26	9330-9331	.	_

Text=This process was originally termed multivariate distance matrix regression by Zapala and Schork and used to test associations between gene expression and related variables.
65-1	9332-9336	This	_
65-2	9337-9344	process	_
65-3	9345-9348	was	_
65-4	9349-9359	originally	_
65-5	9360-9366	termed	_
65-6	9367-9379	multivariate	_
65-7	9380-9388	distance	_
65-8	9389-9395	matrix	_
65-9	9396-9406	regression	_
65-10	9407-9409	by	_
65-11	9410-9416	Zapala	_
65-12	9417-9420	and	_
65-13	9421-9427	Schork	_
65-14	9428-9431	and	_
65-15	9432-9436	used	_
65-16	9437-9439	to	_
65-17	9440-9444	test	_
65-18	9445-9457	associations	_
65-19	9458-9465	between	_
65-20	9466-9470	gene	_
65-21	9471-9481	expression	_
65-22	9482-9485	and	_
65-23	9486-9493	related	_
65-24	9494-9503	variables	_
65-25	9504-9505	.	_

Text=Shezhad et al.
66-1	9506-9513	Shezhad	_
66-2	9514-9516	et	_
66-3	9517-9519	al	_
66-4	9520-9521	.	_

Text=then used their framework for testing the relationship between variables of interest and a matrix of distances where the matrix is between-subject similarity in whole-brain functional connectivity.
67-1	9522-9526	then	_
67-2	9527-9531	used	_
67-3	9532-9537	their	_
67-4	9538-9547	framework	_
67-5	9548-9551	for	_
67-6	9552-9559	testing	_
67-7	9560-9563	the	_
67-8	9564-9576	relationship	_
67-9	9577-9584	between	_
67-10	9585-9594	variables	_
67-11	9595-9597	of	_
67-12	9598-9606	interest	_
67-13	9607-9610	and	_
67-14	9611-9612	a	_
67-15	9613-9619	matrix	_
67-16	9620-9622	of	_
67-17	9623-9632	distances	_
67-18	9633-9638	where	_
67-19	9639-9642	the	_
67-20	9643-9649	matrix	_
67-21	9650-9652	is	_
67-22	9653-9668	between-subject	_
67-23	9669-9679	similarity	_
67-24	9680-9682	in	_
67-25	9683-9694	whole-brain	_
67-26	9695-9705	functional	_
67-27	9706-9718	connectivity	_
67-28	9719-9720	.	_

Text=This test consists of first forming a distance matrix among n participants where d = the between subject distance metric calculated above.
68-1	9721-9725	This	_
68-2	9726-9730	test	_
68-3	9731-9739	consists	_
68-4	9740-9742	of	_
68-5	9743-9748	first	_
68-6	9749-9756	forming	_
68-7	9757-9758	a	_
68-8	9759-9767	distance	_
68-9	9768-9774	matrix	_
68-10	9775-9780	among	_
68-11	9781-9782	n	_
68-12	9783-9795	participants	_
68-13	9796-9801	where	_
68-14	9802-9803	d	_
68-15	9804-9805	=	_
68-16	9806-9809	the	_
68-17	9810-9817	between	_
68-18	9818-9825	subject	_
68-19	9826-9834	distance	_
68-20	9835-9841	metric	_
68-21	9842-9852	calculated	_
68-22	9853-9858	above	_
68-23	9859-9860	.	_

Text=Next, this matrix is used to create a Gower ’ s centered matrix, in which n is the number of participants, I is the n × n identity matrix, and 1 is a vector of n 1s.
69-1	9861-9865	Next	_
69-2	9866-9867	,	_
69-3	9868-9872	this	_
69-4	9873-9879	matrix	_
69-5	9880-9882	is	_
69-6	9883-9887	used	_
69-7	9888-9890	to	_
69-8	9891-9897	create	_
69-9	9898-9899	a	_
69-10	9900-9905	Gower	_
69-11	9906-9907	’	_
69-12	9908-9909	s	_
69-13	9910-9918	centered	_
69-14	9919-9925	matrix	_
69-15	9926-9927	,	_
69-16	9928-9930	in	_
69-17	9931-9936	which	_
69-18	9937-9938	n	_
69-19	9939-9941	is	_
69-20	9942-9945	the	_
69-21	9946-9952	number	_
69-22	9953-9955	of	_
69-23	9956-9968	participants	_
69-24	9969-9970	,	_
69-25	9971-9972	I	_
69-26	9973-9975	is	_
69-27	9976-9979	the	_
69-28	9980-9981	n	_
69-29	9982-9983	×	_
69-30	9984-9985	n	_
69-31	9986-9994	identity	_
69-32	9995-10001	matrix	_
69-33	10002-10003	,	_
69-34	10004-10007	and	_
69-35	10008-10009	1	_
69-36	10010-10012	is	_
69-37	10013-10014	a	_
69-38	10015-10021	vector	_
69-39	10022-10024	of	_
69-40	10025-10026	n	_
69-41	10027-10029	1s	_
69-42	10030-10031	.	_

Text=The F statistic for assessing the relationship between a predictor variable (e.g.
70-1	10032-10035	The	_
70-2	10036-10037	F	_
70-3	10038-10047	statistic	_
70-4	10048-10051	for	_
70-5	10052-10061	assessing	_
70-6	10062-10065	the	_
70-7	10066-10078	relationship	_
70-8	10079-10086	between	_
70-9	10087-10088	a	_
70-10	10089-10098	predictor	_
70-11	10099-10107	variable	_
70-12	10108-10109	(	_
70-13	10110-10113	e.g	_
70-14	10114-10115	.	_

Text=MSCEIT score) and dissimilarities in connectivity is calculated as follows: For m predictor variables, let X be a n× m design matrix of predictor values, and let H = X (XT X) −1 XT be the associated n × m “ hat ” matrix.
71-1	10116-10122	MSCEIT	_
71-2	10123-10128	score	_
71-3	10129-10130	)	_
71-4	10131-10134	and	_
71-5	10135-10150	dissimilarities	_
71-6	10151-10153	in	_
71-7	10154-10166	connectivity	_
71-8	10167-10169	is	_
71-9	10170-10180	calculated	_
71-10	10181-10183	as	_
71-11	10184-10191	follows	_
71-12	10192-10193	:	_
71-13	10194-10197	For	_
71-14	10198-10199	m	_
71-15	10200-10209	predictor	_
71-16	10210-10219	variables	_
71-17	10220-10221	,	_
71-18	10222-10225	let	_
71-19	10226-10227	X	_
71-20	10228-10230	be	_
71-21	10231-10232	a	_
71-22	10233-10235	n×	_
71-23	10236-10237	m	_
71-24	10238-10244	design	_
71-25	10245-10251	matrix	_
71-26	10252-10254	of	_
71-27	10255-10264	predictor	_
71-28	10265-10271	values	_
71-29	10272-10273	,	_
71-30	10274-10277	and	_
71-31	10278-10281	let	_
71-32	10282-10283	H	_
71-33	10284-10285	=	_
71-34	10286-10287	X	_
71-35	10288-10289	(	_
71-36	10290-10292	XT	_
71-37	10293-10294	X	_
71-38	10295-10296	)	_
71-39	10297-10299	−1	_
71-40	10300-10302	XT	_
71-41	10303-10305	be	_
71-42	10306-10309	the	_
71-43	10310-10320	associated	_
71-44	10321-10322	n	_
71-45	10323-10324	×	_
71-46	10325-10326	m	_
71-47	10327-10328	“	_
71-48	10329-10332	hat	_
71-49	10333-10334	”	_
71-50	10335-10341	matrix	_
71-51	10342-10343	.	_

Text=(Figure 1D).
72-1	10344-10345	(	_
72-2	10346-10352	Figure	_
72-3	10353-10355	1D	_
72-4	10356-10357	)	_
72-5	10358-10359	.	_

Text=This process is repeated for every voxel.
73-1	10360-10364	This	_
73-2	10365-10372	process	_
73-3	10373-10375	is	_
73-4	10376-10384	repeated	_
73-5	10385-10388	for	_
73-6	10389-10394	every	_
73-7	10395-10400	voxel	_
73-8	10401-10402	.	_

Text=The result is a whole brain map of how significantly MSCEIT scores are related to functional connectivity at every voxel (Figure 1E).
74-1	10403-10406	The	_
74-2	10407-10413	result	_
74-3	10414-10416	is	_
74-4	10417-10418	a	_
74-5	10419-10424	whole	_
74-6	10425-10430	brain	_
74-7	10431-10434	map	_
74-8	10435-10437	of	_
74-9	10438-10441	how	_
74-10	10442-10455	significantly	_
74-11	10456-10462	MSCEIT	_
74-12	10463-10469	scores	_
74-13	10470-10473	are	_
74-14	10474-10481	related	_
74-15	10482-10484	to	_
74-16	10485-10495	functional	_
74-17	10496-10508	connectivity	_
74-18	10509-10511	at	_
74-19	10512-10517	every	_
74-20	10518-10523	voxel	_
74-21	10524-10525	(	_
74-22	10526-10532	Figure	_
74-23	10533-10535	1E	_
74-24	10536-10537	)	_
74-25	10538-10539	.	_

Text=From that map, ROIs for follow-up analysis are defined based on clusters of significant voxelwise F-statistics.
75-1	10540-10544	From	_
75-2	10545-10549	that	_
75-3	10550-10553	map	_
75-4	10554-10555	,	_
75-5	10556-10560	ROIs	_
75-6	10561-10564	for	_
75-7	10565-10574	follow-up	_
75-8	10575-10583	analysis	_
75-9	10584-10587	are	_
75-10	10588-10595	defined	_
75-11	10596-10601	based	_
75-12	10602-10604	on	_
75-13	10605-10613	clusters	_
75-14	10614-10616	of	_
75-15	10617-10628	significant	_
75-16	10629-10638	voxelwise	_
75-17	10639-10651	F-statistics	_
75-18	10652-10653	.	_

Text=To correct for multiple comparisons, a nonparametric permutation was calculated for voxels that exceeded the significance threshold of p <0.001 and clusters of such with an extent threshold of p <0.05, with a null distribution calculated from 5000 such permutations (Figure 1F).
76-1	10654-10656	To	_
76-2	10657-10664	correct	_
76-3	10665-10668	for	_
76-4	10669-10677	multiple	_
76-5	10678-10689	comparisons	_
76-6	10690-10691	,	_
76-7	10692-10693	a	_
76-8	10694-10707	nonparametric	_
76-9	10708-10719	permutation	_
76-10	10720-10723	was	_
76-11	10724-10734	calculated	_
76-12	10735-10738	for	_
76-13	10739-10745	voxels	_
76-14	10746-10750	that	_
76-15	10751-10759	exceeded	_
76-16	10760-10763	the	_
76-17	10764-10776	significance	_
76-18	10777-10786	threshold	_
76-19	10787-10789	of	_
76-20	10790-10791	p	_
76-21	10792-10793	<	_
76-22	10794-10799	0.001	_
76-23	10800-10803	and	_
76-24	10804-10812	clusters	_
76-25	10813-10815	of	_
76-26	10816-10820	such	_
76-27	10821-10825	with	_
76-28	10826-10828	an	_
76-29	10829-10835	extent	_
76-30	10836-10845	threshold	_
76-31	10846-10848	of	_
76-32	10849-10850	p	_
76-33	10851-10852	<	_
76-34	10853-10857	0.05	_
76-35	10858-10859	,	_
76-36	10860-10864	with	_
76-37	10865-10866	a	_
76-38	10867-10871	null	_
76-39	10872-10884	distribution	_
76-40	10885-10895	calculated	_
76-41	10896-10900	from	_
76-42	10901-10905	5000	_
76-43	10906-10910	such	_
76-44	10911-10923	permutations	_
76-45	10924-10925	(	_
76-46	10926-10932	Figure	_
76-47	10933-10935	1F	_
76-48	10936-10937	)	_
76-49	10938-10939	.	_

Text=Scanner site was included as a covariate in this analysis.
77-1	10940-10947	Scanner	_
77-2	10948-10952	site	_
77-3	10953-10956	was	_
77-4	10957-10965	included	_
77-5	10966-10968	as	_
77-6	10969-10970	a	_
77-7	10971-10980	covariate	_
77-8	10981-10983	in	_
77-9	10984-10988	this	_
77-10	10989-10997	analysis	_
77-11	10998-10999	.	_

Text=The voxelwise threshold was selected to maximize the likelihood of replicability.
78-1	11000-11003	The	_
78-2	11004-11013	voxelwise	_
78-3	11014-11023	threshold	_
78-4	11024-11027	was	_
78-5	11028-11036	selected	_
78-6	11037-11039	to	_
78-7	11040-11048	maximize	_
78-8	11049-11052	the	_
78-9	11053-11063	likelihood	_
78-10	11064-11066	of	_
78-11	11067-11080	replicability	_
78-12	11081-11082	.	_

Text=This analysis identifies anatomical regions where MSCEIT score is significantly related to functional connectivity.
79-1	11083-11087	This	_
79-2	11088-11096	analysis	_
79-3	11097-11107	identifies	_
79-4	11108-11118	anatomical	_
79-5	11119-11126	regions	_
79-6	11127-11132	where	_
79-7	11133-11139	MSCEIT	_
79-8	11140-11145	score	_
79-9	11146-11148	is	_
79-10	11149-11162	significantly	_
79-11	11163-11170	related	_
79-12	11171-11173	to	_
79-13	11174-11184	functional	_
79-14	11185-11197	connectivity	_
79-15	11198-11199	.	_

Text=Recall that at each brain voxel MDMR calculates a distance metric r between subjects by first calculating the temporal correlation in BOLD signal between that voxel and every other brain voxel.
80-1	11200-11206	Recall	_
80-2	11207-11211	that	_
80-3	11212-11214	at	_
80-4	11215-11219	each	_
80-5	11220-11225	brain	_
80-6	11226-11231	voxel	_
80-7	11232-11236	MDMR	_
80-8	11237-11247	calculates	_
80-9	11248-11249	a	_
80-10	11250-11258	distance	_
80-11	11259-11265	metric	_
80-12	11266-11267	r	_
80-13	11268-11275	between	_
80-14	11276-11284	subjects	_
80-15	11285-11287	by	_
80-16	11288-11293	first	_
80-17	11294-11305	calculating	_
80-18	11306-11309	the	_
80-19	11310-11318	temporal	_
80-20	11319-11330	correlation	_
80-21	11331-11333	in	_
80-22	11334-11338	BOLD	_
80-23	11339-11345	signal	_
80-24	11346-11353	between	_
80-25	11354-11358	that	_
80-26	11359-11364	voxel	_
80-27	11365-11368	and	_
80-28	11369-11374	every	_
80-29	11375-11380	other	_
80-30	11381-11386	brain	_
80-31	11387-11392	voxel	_
80-32	11393-11394	.	_

Text=The generated set of temporal correlations is then correlated with the analogous set of temporal correlations from a different subject.
81-1	11395-11398	The	_
81-2	11399-11408	generated	_
81-3	11409-11412	set	_
81-4	11413-11415	of	_
81-5	11416-11424	temporal	_
81-6	11425-11437	correlations	_
81-7	11438-11440	is	_
81-8	11441-11445	then	_
81-9	11446-11456	correlated	_
81-10	11457-11461	with	_
81-11	11462-11465	the	_
81-12	11466-11475	analogous	_
81-13	11476-11479	set	_
81-14	11480-11482	of	_
81-15	11483-11491	temporal	_
81-16	11492-11504	correlations	_
81-17	11505-11509	from	_
81-18	11510-11511	a	_
81-19	11512-11521	different	_
81-20	11522-11529	subject	_
81-21	11530-11531	.	_

Text=The resulting between-subject correlation determines a distance metric that is a measure of between-subject similarity (or dissimilarity) in terms of functional connectivity at that voxel.
82-1	11532-11535	The	_
82-2	11536-11545	resulting	_
82-3	11546-11561	between-subject	_
82-4	11562-11573	correlation	_
82-5	11574-11584	determines	_
82-6	11585-11586	a	_
82-7	11587-11595	distance	_
82-8	11596-11602	metric	_
82-9	11603-11607	that	_
82-10	11608-11610	is	_
82-11	11611-11612	a	_
82-12	11613-11620	measure	_
82-13	11621-11623	of	_
82-14	11624-11639	between-subject	_
82-15	11640-11650	similarity	_
82-16	11651-11652	(	_
82-17	11653-11655	or	_
82-18	11656-11669	dissimilarity	_
82-19	11670-11671	)	_
82-20	11672-11674	in	_
82-21	11675-11680	terms	_
82-22	11681-11683	of	_
82-23	11684-11694	functional	_
82-24	11695-11707	connectivity	_
82-25	11708-11710	at	_
82-26	11711-11715	that	_
82-27	11716-11721	voxel	_
82-28	11722-11723	.	_

Text=Notably, this process disregards spatial information about the voxels that gave rise to between-individual distances e.g.
83-1	11724-11731	Notably	_
83-2	11732-11733	,	_
83-3	11734-11738	this	_
83-4	11739-11746	process	_
83-5	11747-11757	disregards	_
83-6	11758-11765	spatial	_
83-7	11766-11777	information	_
83-8	11778-11783	about	_
83-9	11784-11787	the	_
83-10	11788-11794	voxels	_
83-11	11795-11799	that	_
83-12	11800-11804	gave	_
83-13	11805-11809	rise	_
83-14	11810-11812	to	_
83-15	11813-11831	between-individual	_
83-16	11832-11841	distances	_
83-17	11842-11845	e.g	_
83-18	11846-11847	.	_

Text=Two individuals may be very distant (dissimilar) in the functional connectivity of a voxel in the precuneus, but is their dissimilarity driven by differences in precuneus connectivity to the mPFC or temporal lobe or parietal lobe or all of the above?
84-1	11848-11851	Two	_
84-2	11852-11863	individuals	_
84-3	11864-11867	may	_
84-4	11868-11870	be	_
84-5	11871-11875	very	_
84-6	11876-11883	distant	_
84-7	11884-11885	(	_
84-8	11886-11896	dissimilar	_
84-9	11897-11898	)	_
84-10	11899-11901	in	_
84-11	11902-11905	the	_
84-12	11906-11916	functional	_
84-13	11917-11929	connectivity	_
84-14	11930-11932	of	_
84-15	11933-11934	a	_
84-16	11935-11940	voxel	_
84-17	11941-11943	in	_
84-18	11944-11947	the	_
84-19	11948-11957	precuneus	_
84-20	11958-11959	,	_
84-21	11960-11963	but	_
84-22	11964-11966	is	_
84-23	11967-11972	their	_
84-24	11973-11986	dissimilarity	_
84-25	11987-11993	driven	_
84-26	11994-11996	by	_
84-27	11997-12008	differences	_
84-28	12009-12011	in	_
84-29	12012-12021	precuneus	_
84-30	12022-12034	connectivity	_
84-31	12035-12037	to	_
84-32	12038-12041	the	_
84-33	12042-12046	mPFC	_
84-34	12047-12049	or	_
84-35	12050-12058	temporal	_
84-36	12059-12063	lobe	_
84-37	12064-12066	or	_
84-38	12067-12075	parietal	_
84-39	12076-12080	lobe	_
84-40	12081-12083	or	_
84-41	12084-12087	all	_
84-42	12088-12090	of	_
84-43	12091-12094	the	_
84-44	12095-12100	above	_
84-45	12101-12102	?	_

Text=MDMR as implemented by Shehzad et al.
85-1	12103-12107	MDMR	_
85-2	12108-12110	as	_
85-3	12111-12122	implemented	_
85-4	12123-12125	by	_
85-5	12126-12133	Shehzad	_
85-6	12134-12136	et	_
85-7	12137-12139	al	_
85-8	12140-12141	.	_

Text=does not display this information.
86-1	12142-12146	does	_
86-2	12147-12150	not	_
86-3	12151-12158	display	_
86-4	12159-12163	this	_
86-5	12164-12175	information	_
86-6	12176-12177	.	_

Text=To visualize this spatial information requires follow-on seed-based connectivity analysis.
87-1	12178-12180	To	_
87-2	12181-12190	visualize	_
87-3	12191-12195	this	_
87-4	12196-12203	spatial	_
87-5	12204-12215	information	_
87-6	12216-12224	requires	_
87-7	12225-12234	follow-on	_
87-8	12235-12245	seed-based	_
87-9	12246-12258	connectivity	_
87-10	12259-12267	analysis	_
87-11	12268-12269	.	_

Text=Shehzad et al.
88-1	12270-12277	Shehzad	_
88-2	12278-12280	et	_
88-3	12281-12283	al	_
88-4	12284-12285	.	_

Text=and others have termed this follow-on analysis ‘ post-hoc ’ testing to make clear that this should not be considered independent hypothesis testing nor should it be considered independent validation of the original MDMR finding.
89-1	12286-12289	and	_
89-2	12290-12296	others	_
89-3	12297-12301	have	_
89-4	12302-12308	termed	_
89-5	12309-12313	this	_
89-6	12314-12323	follow-on	_
89-7	12324-12332	analysis	_
89-8	12333-12334	‘	_
89-9	12335-12343	post-hoc	_
89-10	12344-12345	’	_
89-11	12346-12353	testing	_
89-12	12354-12356	to	_
89-13	12357-12361	make	_
89-14	12362-12367	clear	_
89-15	12368-12372	that	_
89-16	12373-12377	this	_
89-17	12378-12384	should	_
89-18	12385-12388	not	_
89-19	12389-12391	be	_
89-20	12392-12402	considered	_
89-21	12403-12414	independent	_
89-22	12415-12425	hypothesis	_
89-23	12426-12433	testing	_
89-24	12434-12437	nor	_
89-25	12438-12444	should	_
89-26	12445-12447	it	_
89-27	12448-12450	be	_
89-28	12451-12461	considered	_
89-29	12462-12473	independent	_
89-30	12474-12484	validation	_
89-31	12485-12487	of	_
89-32	12488-12491	the	_
89-33	12492-12500	original	_
89-34	12501-12505	MDMR	_
89-35	12506-12513	finding	_
89-36	12514-12515	.	_

Text=As in these prior manuscripts, we conducted the MDMR analysis to find anatomical regions where connectivity significantly varied with MSCEIT score and then conducted follow-on seed-based connectivity analysis to examine the spatial distribution of these connectivity differences.
90-1	12516-12518	As	_
90-2	12519-12521	in	_
90-3	12522-12527	these	_
90-4	12528-12533	prior	_
90-5	12534-12545	manuscripts	_
90-6	12546-12547	,	_
90-7	12548-12550	we	_
90-8	12551-12560	conducted	_
90-9	12561-12564	the	_
90-10	12565-12569	MDMR	_
90-11	12570-12578	analysis	_
90-12	12579-12581	to	_
90-13	12582-12586	find	_
90-14	12587-12597	anatomical	_
90-15	12598-12605	regions	_
90-16	12606-12611	where	_
90-17	12612-12624	connectivity	_
90-18	12625-12638	significantly	_
90-19	12639-12645	varied	_
90-20	12646-12650	with	_
90-21	12651-12657	MSCEIT	_
90-22	12658-12663	score	_
90-23	12664-12667	and	_
90-24	12668-12672	then	_
90-25	12673-12682	conducted	_
90-26	12683-12692	follow-on	_
90-27	12693-12703	seed-based	_
90-28	12704-12716	connectivity	_
90-29	12717-12725	analysis	_
90-30	12726-12728	to	_
90-31	12729-12736	examine	_
90-32	12737-12740	the	_
90-33	12741-12748	spatial	_
90-34	12749-12761	distribution	_
90-35	12762-12764	of	_
90-36	12765-12770	these	_
90-37	12771-12783	connectivity	_
90-38	12784-12795	differences	_
90-39	12796-12797	.	_

Text=Seed based connectivity analyses For seed based connectivity analyses we used DPABI to extract the time course of the BOLD signal in a given ROI.
91-1	12798-12802	Seed	_
91-2	12803-12808	based	_
91-3	12809-12821	connectivity	_
91-4	12822-12830	analyses	_
91-5	12831-12834	For	_
91-6	12835-12839	seed	_
91-7	12840-12845	based	_
91-8	12846-12858	connectivity	_
91-9	12859-12867	analyses	_
91-10	12868-12870	we	_
91-11	12871-12875	used	_
91-12	12876-12881	DPABI	_
91-13	12882-12884	to	_
91-14	12885-12892	extract	_
91-15	12893-12896	the	_
91-16	12897-12901	time	_
91-17	12902-12908	course	_
91-18	12909-12911	of	_
91-19	12912-12915	the	_
91-20	12916-12920	BOLD	_
91-21	12921-12927	signal	_
91-22	12928-12930	in	_
91-23	12931-12932	a	_
91-24	12933-12938	given	_
91-25	12939-12942	ROI	_
91-26	12943-12944	.	_

Text=We then generated whole brain maps of z-transformed Pearson ’ s correlation coefficients.
92-1	12945-12947	We	_
92-2	12948-12952	then	_
92-3	12953-12962	generated	_
92-4	12963-12968	whole	_
92-5	12969-12974	brain	_
92-6	12975-12979	maps	_
92-7	12980-12982	of	_
92-8	12983-12996	z-transformed	_
92-9	12997-13004	Pearson	_
92-10	13005-13006	’	_
92-11	13007-13008	s	_
92-12	13009-13020	correlation	_
92-13	13021-13033	coefficients	_
92-14	13034-13035	.	_

Text=These maps were entered into SPM12 (Statistical and Parametric Mapping, http: //www.fil.ion.ucl.ac.uk/spm).
93-1	13036-13041	These	_
93-2	13042-13046	maps	_
93-3	13047-13051	were	_
93-4	13052-13059	entered	_
93-5	13060-13064	into	_
93-6	13065-13070	SPM12	_
93-7	13071-13072	(	_
93-8	13073-13084	Statistical	_
93-9	13085-13088	and	_
93-10	13089-13099	Parametric	_
93-11	13100-13107	Mapping	_
93-12	13108-13109	,	_
93-13	13110-13114	http	_
93-14	13115-13116	:	_
93-15	13117-13144	//www.fil.ion.ucl.ac.uk/spm	_
93-16	13145-13146	)	_
93-17	13147-13148	.	_

Text=For ROIs generated from MDMR above, we regressed the maps against MSCEIT score to generate spatial maps of how whole brain functional connectivity to the ROIs varies with MSCEIT score.
94-1	13149-13152	For	_
94-2	13153-13157	ROIs	_
94-3	13158-13167	generated	_
94-4	13168-13172	from	_
94-5	13173-13177	MDMR	_
94-6	13178-13183	above	_
94-7	13184-13185	,	_
94-8	13186-13188	we	_
94-9	13189-13198	regressed	_
94-10	13199-13202	the	_
94-11	13203-13207	maps	_
94-12	13208-13215	against	_
94-13	13216-13222	MSCEIT	_
94-14	13223-13228	score	_
94-15	13229-13231	to	_
94-16	13232-13240	generate	_
94-17	13241-13248	spatial	_
94-18	13249-13253	maps	_
94-19	13254-13256	of	_
94-20	13257-13260	how	_
94-21	13261-13266	whole	_
94-22	13267-13272	brain	_
94-23	13273-13283	functional	_
94-24	13284-13296	connectivity	_
94-25	13297-13299	to	_
94-26	13300-13303	the	_
94-27	13304-13308	ROIs	_
94-28	13309-13315	varies	_
94-29	13316-13320	with	_
94-30	13321-13327	MSCEIT	_
94-31	13328-13333	score	_
94-32	13334-13335	.	_

Text=To control for participant variables of non-interest, we performed these analyses with age, race, diagnosis (Schizophrenia or Healthy Comparison), scanner site, and sex as additional covariates.
95-1	13336-13338	To	_
95-2	13339-13346	control	_
95-3	13347-13350	for	_
95-4	13351-13362	participant	_
95-5	13363-13372	variables	_
95-6	13373-13375	of	_
95-7	13376-13388	non-interest	_
95-8	13389-13390	,	_
95-9	13391-13393	we	_
95-10	13394-13403	performed	_
95-11	13404-13409	these	_
95-12	13410-13418	analyses	_
95-13	13419-13423	with	_
95-14	13424-13427	age	_
95-15	13428-13429	,	_
95-16	13430-13434	race	_
95-17	13435-13436	,	_
95-18	13437-13446	diagnosis	_
95-19	13447-13448	(	_
95-20	13449-13462	Schizophrenia	_
95-21	13463-13465	or	_
95-22	13466-13473	Healthy	_
95-23	13474-13484	Comparison	_
95-24	13485-13486	)	_
95-25	13487-13488	,	_
95-26	13489-13496	scanner	_
95-27	13497-13501	site	_
95-28	13502-13503	,	_
95-29	13504-13507	and	_
95-30	13508-13511	sex	_
95-31	13512-13514	as	_
95-32	13515-13525	additional	_
95-33	13526-13536	covariates	_
95-34	13537-13538	.	_

Text=To control for movement effects we also included individual mean FD (framewise displacement) as a covariate as a subject-level correction for motion effects in all subjects.
96-1	13539-13541	To	_
96-2	13542-13549	control	_
96-3	13550-13553	for	_
96-4	13554-13562	movement	_
96-5	13563-13570	effects	_
96-6	13571-13573	we	_
96-7	13574-13578	also	_
96-8	13579-13587	included	_
96-9	13588-13598	individual	_
96-10	13599-13603	mean	_
96-11	13604-13606	FD	_
96-12	13607-13608	(	_
96-13	13609-13618	framewise	_
96-14	13619-13631	displacement	_
96-15	13632-13633	)	_
96-16	13634-13636	as	_
96-17	13637-13638	a	_
96-18	13639-13648	covariate	_
96-19	13649-13651	as	_
96-20	13652-13653	a	_
96-21	13654-13667	subject-level	_
96-22	13668-13678	correction	_
96-23	13679-13682	for	_
96-24	13683-13689	motion	_
96-25	13690-13697	effects	_
96-26	13698-13700	in	_
96-27	13701-13704	all	_
96-28	13705-13713	subjects	_
96-29	13714-13715	.	_

Text=In addition to including mean FD as a covariate in the seed-based connectivity analysis, we did not observe a significant correlation between MSCEIT score and either mean within-scanner movement as measured by average framewise displacement (r=−.109, p=.268), nor did we observe a significant correlation between MSCEIT score and the number of volumes remaining after preprocessing for movement (r=0.14 and p=0.15).
97-1	13716-13718	In	_
97-2	13719-13727	addition	_
97-3	13728-13730	to	_
97-4	13731-13740	including	_
97-5	13741-13745	mean	_
97-6	13746-13748	FD	_
97-7	13749-13751	as	_
97-8	13752-13753	a	_
97-9	13754-13763	covariate	_
97-10	13764-13766	in	_
97-11	13767-13770	the	_
97-12	13771-13781	seed-based	_
97-13	13782-13794	connectivity	_
97-14	13795-13803	analysis	_
97-15	13804-13805	,	_
97-16	13806-13808	we	_
97-17	13809-13812	did	_
97-18	13813-13816	not	_
97-19	13817-13824	observe	_
97-20	13825-13826	a	_
97-21	13827-13838	significant	_
97-22	13839-13850	correlation	_
97-23	13851-13858	between	_
97-24	13859-13865	MSCEIT	_
97-25	13866-13871	score	_
97-26	13872-13875	and	_
97-27	13876-13882	either	_
97-28	13883-13887	mean	_
97-29	13888-13902	within-scanner	_
97-30	13903-13911	movement	_
97-31	13912-13914	as	_
97-32	13915-13923	measured	_
97-33	13924-13926	by	_
97-34	13927-13934	average	_
97-35	13935-13944	framewise	_
97-36	13945-13957	displacement	_
97-37	13958-13959	(	_
97-38	13960-13967	r=−.109	_
97-39	13968-13969	,	_
97-40	13970-13976	p=.268	_
97-41	13977-13978	)	_
97-42	13979-13980	,	_
97-43	13981-13984	nor	_
97-44	13985-13988	did	_
97-45	13989-13991	we	_
97-46	13992-13999	observe	_
97-47	14000-14001	a	_
97-48	14002-14013	significant	_
97-49	14014-14025	correlation	_
97-50	14026-14033	between	_
97-51	14034-14040	MSCEIT	_
97-52	14041-14046	score	_
97-53	14047-14050	and	_
97-54	14051-14054	the	_
97-55	14055-14061	number	_
97-56	14062-14064	of	_
97-57	14065-14072	volumes	_
97-58	14073-14082	remaining	_
97-59	14083-14088	after	_
97-60	14089-14102	preprocessing	_
97-61	14103-14106	for	_
97-62	14107-14115	movement	_
97-63	14116-14117	(	_
97-64	14118-14124	r=0.14	_
97-65	14125-14128	and	_
97-66	14129-14135	p=0.15	_
97-67	14136-14137	)	_
97-68	14138-14139	.	_

Text=To control for the effects of medication regimen, the analyses were re-performed with prescribed anti-psychotic dosage (in chlorpromazine equivalents, CPZE) as a covariate within the schizophrenia/schizoaffective group.
98-1	14140-14142	To	_
98-2	14143-14150	control	_
98-3	14151-14154	for	_
98-4	14155-14158	the	_
98-5	14159-14166	effects	_
98-6	14167-14169	of	_
98-7	14170-14180	medication	_
98-8	14181-14188	regimen	_
98-9	14189-14190	,	_
98-10	14191-14194	the	_
98-11	14195-14203	analyses	_
98-12	14204-14208	were	_
98-13	14209-14221	re-performed	_
98-14	14222-14226	with	_
98-15	14227-14237	prescribed	_
98-16	14238-14252	anti-psychotic	_
98-17	14253-14259	dosage	_
98-18	14260-14261	(	_
98-19	14262-14264	in	_
98-20	14265-14279	chlorpromazine	_
98-21	14280-14291	equivalents	_
98-22	14292-14293	,	_
98-23	14294-14298	CPZE	_
98-24	14299-14300	)	_
98-25	14301-14303	as	_
98-26	14304-14305	a	_
98-27	14306-14315	covariate	_
98-28	14316-14322	within	_
98-29	14323-14326	the	_
98-30	14327-14356	schizophrenia/schizoaffective	_
98-31	14357-14362	group	_
98-32	14363-14364	.	_

Text=For other, subsequent ROI based connectivity analyses described below, we used DPABI to calculate the time course of the average BOLD signal in a sphere, and then generated whole brain maps of z-transformed Pearson ’ s correlation coefficients.
99-1	14365-14368	For	_
99-2	14369-14374	other	_
99-3	14375-14376	,	_
99-4	14377-14387	subsequent	_
99-5	14388-14391	ROI	_
99-6	14392-14397	based	_
99-7	14398-14410	connectivity	_
99-8	14411-14419	analyses	_
99-9	14420-14429	described	_
99-10	14430-14435	below	_
99-11	14436-14437	,	_
99-12	14438-14440	we	_
99-13	14441-14445	used	_
99-14	14446-14451	DPABI	_
99-15	14452-14454	to	_
99-16	14455-14464	calculate	_
99-17	14465-14468	the	_
99-18	14469-14473	time	_
99-19	14474-14480	course	_
99-20	14481-14483	of	_
99-21	14484-14487	the	_
99-22	14488-14495	average	_
99-23	14496-14500	BOLD	_
99-24	14501-14507	signal	_
99-25	14508-14510	in	_
99-26	14511-14512	a	_
99-27	14513-14519	sphere	_
99-28	14520-14521	,	_
99-29	14522-14525	and	_
99-30	14526-14530	then	_
99-31	14531-14540	generated	_
99-32	14541-14546	whole	_
99-33	14547-14552	brain	_
99-34	14553-14557	maps	_
99-35	14558-14560	of	_
99-36	14561-14574	z-transformed	_
99-37	14575-14582	Pearson	_
99-38	14583-14584	’	_
99-39	14585-14586	s	_
99-40	14587-14598	correlation	_
99-41	14599-14611	coefficients	_
99-42	14612-14613	.	_

Text=We then used SPM12 to generate single-sample t-tests of these connectivity maps.
100-1	14614-14616	We	_
100-2	14617-14621	then	_
100-3	14622-14626	used	_
100-4	14627-14632	SPM12	_
100-5	14633-14635	to	_
100-6	14636-14644	generate	_
100-7	14645-14658	single-sample	_
100-8	14659-14666	t-tests	_
100-9	14667-14669	of	_
100-10	14670-14675	these	_
100-11	14676-14688	connectivity	_
100-12	14689-14693	maps	_
100-13	14694-14695	.	_

Text=Correlations between ROI to ROI connectivity and emotional intelligence Partial correlation coefficients and statistic values were calculated in R using the ppcor package.
101-1	14696-14708	Correlations	_
101-2	14709-14716	between	_
101-3	14717-14720	ROI	_
101-4	14721-14723	to	_
101-5	14724-14727	ROI	_
101-6	14728-14740	connectivity	_
101-7	14741-14744	and	_
101-8	14745-14754	emotional	_
101-9	14755-14767	intelligence	_
101-10	14768-14775	Partial	_
101-11	14776-14787	correlation	_
101-12	14788-14800	coefficients	_
101-13	14801-14804	and	_
101-14	14805-14814	statistic	_
101-15	14815-14821	values	_
101-16	14822-14826	were	_
101-17	14827-14837	calculated	_
101-18	14838-14840	in	_
101-19	14841-14842	R	_
101-20	14843-14848	using	_
101-21	14849-14852	the	_
101-22	14853-14858	ppcor	_
101-23	14859-14866	package	_
101-24	14867-14868	.	_

Text=Nth-order partial correlation coefficients are Pearson ’ s correlations between two variables of interest while controlling for n covariates.
102-1	14869-14878	Nth-order	_
102-2	14879-14886	partial	_
102-3	14887-14898	correlation	_
102-4	14899-14911	coefficients	_
102-5	14912-14915	are	_
102-6	14916-14923	Pearson	_
102-7	14924-14925	’	_
102-8	14926-14927	s	_
102-9	14928-14940	correlations	_
102-10	14941-14948	between	_
102-11	14949-14952	two	_
102-12	14953-14962	variables	_
102-13	14963-14965	of	_
102-14	14966-14974	interest	_
102-15	14975-14980	while	_
102-16	14981-14992	controlling	_
102-17	14993-14996	for	_
102-18	14997-14998	n	_
102-19	14999-15009	covariates	_
102-20	15010-15011	.	_

Text=Categorical covariates were binarized.
103-1	15012-15023	Categorical	_
103-2	15024-15034	covariates	_
103-3	15035-15039	were	_
103-4	15040-15049	binarized	_
103-5	15050-15051	.	_

Text=Structural MRI Analysis Structural MPRAGE images were checked for artifacts and were processed using Freesurfer 6 (http: //surfer.nmr.mgh.harvard.edu/).
104-1	15052-15062	Structural	_
104-2	15063-15066	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
104-3	15067-15075	Analysis	_
104-4	15076-15086	Structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
104-5	15087-15093	MPRAGE	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
104-6	15094-15100	images	_
104-7	15101-15105	were	_
104-8	15106-15113	checked	_
104-9	15114-15117	for	_
104-10	15118-15127	artifacts	_
104-11	15128-15131	and	_
104-12	15132-15136	were	_
104-13	15137-15146	processed	_
104-14	15147-15152	using	_
104-15	15153-15163	Freesurfer	_
104-16	15164-15165	6	_
104-17	15166-15167	(	_
104-18	15168-15172	http	_
104-19	15173-15174	:	_
104-20	15175-15204	//surfer.nmr.mgh.harvard.edu/	_
104-21	15205-15206	)	_
104-22	15207-15208	.	_

Text=The images went through first-level auto-reconstruction to register the scans in standard space and skull strip the brains.
105-1	15209-15212	The	_
105-2	15213-15219	images	_
105-3	15220-15224	went	_
105-4	15225-15232	through	_
105-5	15233-15244	first-level	_
105-6	15245-15264	auto-reconstruction	_
105-7	15265-15267	to	_
105-8	15268-15276	register	_
105-9	15277-15280	the	_
105-10	15281-15286	scans	_
105-11	15287-15289	in	_
105-12	15290-15298	standard	_
105-13	15299-15304	space	_
105-14	15305-15308	and	_
105-15	15309-15314	skull	_
105-16	15315-15320	strip	_
105-17	15321-15324	the	_
105-18	15325-15331	brains	_
105-19	15332-15333	.	_

Text=One rater (OL) edited the images to remove dura, sinuses and vessels that could interfere with segmentation.
106-1	15334-15337	One	_
106-2	15338-15343	rater	_
106-3	15344-15345	(	_
106-4	15346-15348	OL	_
106-5	15349-15350	)	_
106-6	15351-15357	edited	_
106-7	15358-15361	the	_
106-8	15362-15368	images	_
106-9	15369-15371	to	_
106-10	15372-15378	remove	_
106-11	15379-15383	dura	_
106-12	15384-15385	,	_
106-13	15386-15393	sinuses	_
106-14	15394-15397	and	_
106-15	15398-15405	vessels	_
106-16	15406-15410	that	_
106-17	15411-15416	could	_
106-18	15417-15426	interfere	_
106-19	15427-15431	with	_
106-20	15432-15444	segmentation	_
106-21	15445-15446	.	_

Text=After visual inspection, 98 images were retained for analysis.
107-1	15447-15452	After	_
107-2	15453-15459	visual	_
107-3	15460-15470	inspection	_
107-4	15471-15472	,	_
107-5	15473-15475	98	_
107-6	15476-15482	images	_
107-7	15483-15487	were	_
107-8	15488-15496	retained	_
107-9	15497-15500	for	_
107-10	15501-15509	analysis	_
107-11	15510-15511	.	_

Text=The images then went through second and third level auto-reconstruction to register the brains to the Desikan-Killiany atlas and extract sulcal depth measurements.
108-1	15512-15515	The	_
108-2	15516-15522	images	_
108-3	15523-15527	then	_
108-4	15528-15532	went	_
108-5	15533-15540	through	_
108-6	15541-15547	second	_
108-7	15548-15551	and	_
108-8	15552-15557	third	_
108-9	15558-15563	level	_
108-10	15564-15583	auto-reconstruction	_
108-11	15584-15586	to	_
108-12	15587-15595	register	_
108-13	15596-15599	the	_
108-14	15600-15606	brains	_
108-15	15607-15609	to	_
108-16	15610-15613	the	_
108-17	15614-15630	Desikan-Killiany	_
108-18	15631-15636	atlas	_
108-19	15637-15640	and	_
108-20	15641-15648	extract	_
108-21	15649-15655	sulcal	_
108-22	15656-15661	depth	_
108-23	15662-15674	measurements	_
108-24	15675-15676	.	_

Text=Sulcal depth in Freesurfer is the integrated dot product of the movement vector and the surface normal during inflation.
109-1	15677-15683	Sulcal	_
109-2	15684-15689	depth	_
109-3	15690-15692	in	_
109-4	15693-15703	Freesurfer	_
109-5	15704-15706	is	_
109-6	15707-15710	the	_
109-7	15711-15721	integrated	_
109-8	15722-15725	dot	_
109-9	15726-15733	product	_
109-10	15734-15736	of	_
109-11	15737-15740	the	_
109-12	15741-15749	movement	_
109-13	15750-15756	vector	_
109-14	15757-15760	and	_
109-15	15761-15764	the	_
109-16	15765-15772	surface	_
109-17	15773-15779	normal	_
109-18	15780-15786	during	_
109-19	15787-15796	inflation	_
109-20	15797-15798	.	_

Text=Deep regions therefore are expressed as positive values as they move outwards while more superficial regions move inwards.
110-1	15799-15803	Deep	_
110-2	15804-15811	regions	_
110-3	15812-15821	therefore	_
110-4	15822-15825	are	_
110-5	15826-15835	expressed	_
110-6	15836-15838	as	_
110-7	15839-15847	positive	_
110-8	15848-15854	values	_
110-9	15855-15857	as	_
110-10	15858-15862	they	_
110-11	15863-15867	move	_
110-12	15868-15876	outwards	_
110-13	15877-15882	while	_
110-14	15883-15887	more	_
110-15	15888-15899	superficial	_
110-16	15900-15907	regions	_
110-17	15908-15912	move	_
110-18	15913-15920	inwards	_
110-19	15921-15922	.	_

Text=Units are the standard deviation from the median value.
111-1	15923-15928	Units	_
111-2	15929-15932	are	_
111-3	15933-15936	the	_
111-4	15937-15945	standard	_
111-5	15946-15955	deviation	_
111-6	15956-15960	from	_
111-7	15961-15964	the	_
111-8	15965-15971	median	_
111-9	15972-15977	value	_
111-10	15978-15979	.	_

Text=Table and figure generation Graphs of relationships between emotional intelligence and structural/functional measures were generated using R. Projections of ROIs and T contrast maps onto cortical surfaces was accomplished using FSL, Caret and Surf Ice (www.nitrc.org/projects/surfice/).
112-1	15980-15985	Table	_
112-2	15986-15989	and	_
112-3	15990-15996	figure	_
112-4	15997-16007	generation	_
112-5	16008-16014	Graphs	_
112-6	16015-16017	of	_
112-7	16018-16031	relationships	_
112-8	16032-16039	between	_
112-9	16040-16049	emotional	_
112-10	16050-16062	intelligence	_
112-11	16063-16066	and	_
112-12	16067-16088	structural/functional	_
112-13	16089-16097	measures	_
112-14	16098-16102	were	_
112-15	16103-16112	generated	_
112-16	16113-16118	using	_
112-17	16119-16121	R.	_
112-18	16122-16133	Projections	_
112-19	16134-16136	of	_
112-20	16137-16141	ROIs	_
112-21	16142-16145	and	_
112-22	16146-16147	T	_
112-23	16148-16156	contrast	_
112-24	16157-16161	maps	_
112-25	16162-16166	onto	_
112-26	16167-16175	cortical	_
112-27	16176-16184	surfaces	_
112-28	16185-16188	was	_
112-29	16189-16201	accomplished	_
112-30	16202-16207	using	_
112-31	16208-16211	FSL	_
112-32	16212-16213	,	_
112-33	16214-16219	Caret	_
112-34	16220-16223	and	_
112-35	16224-16228	Surf	_
112-36	16229-16232	Ice	_
112-37	16233-16234	(	_
112-38	16235-16266	www.nitrc.org/projects/surfice/	_
112-39	16267-16268	)	_
112-40	16269-16270	.	_

